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 Abstract 
Genetically modified carnation (Dianthus caryophyllus L.) line IFD-26407-2 with product 
name Moonvelvet™, expresses three introduced traits. The cytb5 gene and the f3′5′h (Hf1) 
gene from Petunia x hybrida, coding for cytochrome b5 (CYTB5) and flavonoid 3′,5′-
hydroxylase (F3′5′H), respectively, lead to the biosynthesis of anthocyanin pigments, which 
confer the desired violet/blue colour to the flowers. A mutated als gene (SuRB) from 
Nicotiana tabacum has also been inserted, coding for an acetolactate synthase (ALS) variant 
protein and thereby conferring tolerance to the active, ALS-inhibiting, herbicidal substances 
chlorimuron, thifensulfuron and sulfonylureas, used to facilitate the selection of GM shoots 
during genetic transformation. Bioinformatic analyses of the inserted DNA and flanking 
sequences in carnation Moonvelvet IFD-26407-2 have not indicated a potential production of 
putative harmful proteins or polypeptides caused by the genetic modification. Genomic 
stability of the functional insert and consistent expression of the cytb5 and f3′5′h (Hf1) 
genes, have been shown over several generations of carnation Moonvelvet IFD-26407-2. 
Data reported from several field trials show that carnation Moonvelvet IFD-26407-2 petals 
contain higher levels of the anthocyanins delphinidin and cyanidin, and lower levels of 
pelargonidin compared to the non-GM (conventional) carnation counterpart Cerise Westpearl 
(CW). Other morphological traits were reported and along with differing petal colour, 
carnation Moonvelvet IFD-26407-2 differed significantly in 10 traits compared to 
conventional carnation counterpart CW. Aqueous extracts from leaves or petals showed no 
mutagenic activity in vitro. ALS, CYTB5, and F3’5’H proteins do not show sequence 
resemblance to known toxins or IgE-dependent allergens, nor have they been reported to be 
toxic to animals or cause IgE-mediated allergic reactions. The anthocyanins delphinidin and 
cyanidin are present in numerous foods and are also approved food additives. Carnations are 
cultivated in Norway, but since 1) the intended uses includes import of cut flowers for 
ornamental use only, 2) the spread and viability of pollen from the cut flowers is low, 3) seed 
formation in cut flowers is unlikely to occur, and 4) spread of inserted genes to target or 
non-target organisms is either unlikely to occur or is not of biological relevance, the VKM 
GMO Panel does not consider that carnation Moonvelvet IFD-26407-2 represents an 
environmental risk in Norway.  
Considering that carnation Moonvelvet IFD-26407-2 is not intended for cultivation or use as 
food or feed, the VKM GMO Panel considers that comparative analysis of the newly 
synthesised anthocyanin pigments delphinidin, cyanidin and pelargonidin in its petals is 
sufficient for the risk assessment. The reported morphological differences between 
Moonvelvet IFD-26407-2 and its conventional carnation counterpart Cerise Westpearl (CW) 
do not raise safety concerns. It is unlikely that either the CYTB5, F3’5’H or ALS proteins, or 
the delphinidin or cyanidin pigments, will introduce a toxic or allergenic potential in 
Moonvelvet IFD-26407-2.  
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Based on current knowledge and information supplied by the applicant, and considering the 
intended uses, which exclude cultivation and use as food and feed, the VKM GMO Panel 
concludes that Moonvelvet IFD-26407-2 is as safe as its conventional counterpart CW.  
Based on the current knowledge and considering its import, distribution and intended use as 
cut ornamental flowers, the VKM GMO Panel concludes that it is unlikely that carnation 
Moonvelvet IFD-26407-2 will have any adverse effects on the biotic or abiotic environment in 
Norway. 
Summary 
In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian 
Scientific Committee for Food Safety (VKM) has been requested by the Norwegian 
Environment Agency (formerly Norwegian Directorate for Nature Management) and the 
Norwegian Food Safety Authority (NFSA) to conduct final health and environmental risk 
assessments of all genetically modified organisms (GMOs) and products containing or 
consisting of GMOs that are authorised in the European Union under Directive 2001/18/EC or 
Regulation 1829/2003/EC. The request covers scope(s) relevant to the Gene Technology Act. 
The request does not cover GMOs that VKM already has conducted its final risk assessments 
on. However, the Agency and NFSA requests VKM to consider whether updates or other 
changes to earlier submitted assessments are necessary. 
The genetically modified carnation (Dianthus caryophyllus L.) Moonvelvet IFD-26407-2 
(Unique Identifier IFD-264Ø7-2) with modified flower colour is approved under Directive 
2001/18/EC for import as cut flowers for ornamental use since 24 April 2015 (Application 
C/NL/09/02, Commission Decision 2015/694). The scope of the application is restricted to 
flowers produced by vegetative propagation, and do not cover progeny derived from sexual 
crosses with Moonvelvet IFD-26407-2 cultivar. A condition for placing on the market is a 
label or document accompanying the product that states that it is genetically modified and 
the words “not for human or animal consumption nor for cultivation”. 
The current safety and environmental risk assessment of the carnation Moonvelvet IFD-
26407-2 is based on information provided by the applicant in the application C/NL/09/02, 
relevant peer-reviewed scientific literature, and scientific opinions from EFSA (EFSA, 2014b). 
Except for a synopsis of more recent literature, this draft opinion is to a large extent a 
summary of the above-mentioned EFSA report, which is provided in Appendix I, and readers 
are referred to this for details.  
The VKM GMO Panel has evaluated carnation Moonvelvet IFD-26407-2 with reference to its 
intended uses in the European Economic Area (EEA), and according to the principles 
described in the Norwegian Food Act, the Norwegian Gene Technology Act and regulations 
relating to impact assessment pursuant to the Gene Technology Act, and Directive 
2001/18/EC on the deliberate release into the environment of genetically modified 
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organisms. VKM has also decided to take account of the appropriate principles described in 
the EFSA guidelines on the risk assessment of GM plants used for non-food/feed purposes 
(EFSA, 2009a), the risk assessment of GM plants and derived food and feed (EFSA, 2006a; 
EFSA, 2011b), the environmental risk assessment of GM plants (EFSA, 2010a), selection of 
comparators for the risk assessment of GM plants (EFSA, 2011a), and for the post-market 
environmental monitoring of GM plants (EFSA, 2011c). 
The scientific risk assessment of carnation Moonvelvet IFD-26407-2 includes molecular 
characterisation of the inserted DNA and expression of novel proteins and other relevant 
components, comparative assessment of phenotypic characteristics, toxicity and allergenicity, 
unintended effects on plant fitness, potential for gene transfer, interactions between the GM 
plant and target and non-target organisms, and effects on biogeochemical processes.  
It is emphasised that the VKM mandate does not include assessments of contribution to 
sustainable development, societal utility or ethical considerations, according to the 
Norwegian Gene Technology Act and Regulations relating to impact assessment pursuant to 
the Gene Technology Act. These considerations are therefore not part of the risk assessment 
provided by the VKM Panel on Genetically Modified Organisms. Likewise, the VKM mandate 
does not include evaluations of herbicide residues in food and feed from genetically modified 
plants. 
Carnation Moonvelvet IFD-26407-2 expresses three introduced traits: cytb5 gene coding for 
cytochrome b5 (CYTB5) and f3′5′h gene coding for flavonoid 3′,5′-hydroxylase (F3′5′H), 
both from Petunia x hybrid, and which confer the violet/blue colour to the flowers. A 
mutated als gene (SuRB) from Nicotiana tabacum is also inserted, which codes for an 
acetolactate synthase (ALS) variant protein, conferring herbicide tolerance and used to 
facilitate the selection of GM shoots during genetic transformation. 
Molecular characterisation  
The molecular characterisation provided by the applicant shows that Carnation Moonvelvet 
IFD-26407-2 contains one transgenic locus with the full length transfer-DNA-sequence (T-
DNA) from the transformation vector pCGP2355. The transferred T-DNA includes functional 
single copies of each of the three genes f3′5′h, cytb5 and als. Southern blot and PCR 
analyses indicate that no plasmid backbone sequences were integrated. Sequence analyses 
show no disruption of known endogenous genes. Bioinformatic analyses of putative 
translation products from new open reading frames (ORFs) within the insert and junction 
sites returned no relevant similarities to known toxins. Partial identities were indicated for 
the ALS protein and two ORFs with known allergens, however these similarities are 
considered negligible. Presence of transcripts corresponding to the f3′5′h, cytb5 and als 
genes in petals was shown by Northern blot analysis. Expression levels were not quantified. 
Activity of F3’5’H and Cytb5 enzymes and production of delphinidin was further indicated by 
the altered flower colour and metabolite analysis with both thin layer chromatography (TLC) 
and high-pressure liquid chromatography (HPLC). The level of delphinidin in flowers of 
Moonvelvet IFD-26407-2 was approximately 2.87 mg/g fresh weight. Tolerance to 
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sulfonylurea herbicides indicated the activity of the ALS protein. No relevant changes in the 
introduced trait, i.e. the particular flower colour, have been reported during cultivation of 
carnation of Moonvelvet IFD-26407-2, indicating genetic stability. 
Based on current knowledge and the information provided by the applicant, the VKM GMO 
panel concludes that the molecular characterisation of carnation Moonvelvet IFD-26407-2 
does not indicate a safety concern.  
Comparative assessments 
Considering the intended use of Moonvelvet IFD-26407-2, which excludes cultivation and use 
in food and feed, compositional studies were limited to the content of the three anthocyanin 
pigments delphinidin, cyanidin and pelargonidin. Compared to its non-GM parental cultivar 
Cerise Westpearl (CW), carnation Moonvelvet IFD-26407-2 petals contained higher levels of 
delphinidin and cyanidin and lower levels of pelargonidin, confirming the intended effects of 
the genetic modification. Other morphological traits were assessed and revealed that along 
with differing petal colour, carnation Moonvelvet IFD-26407-2 differed significantly in 10 
traits compared to carnation CW. None of the reported differences in compositional or 
morphological traits were expected to influence the risk scenario upon accidental release to 
the environment or intake of the GM carnation. 
Based on current knowledge and information provided by the applicant, and considering the 
intended use of carnation Moonvelvet IFD-26407-2, which excludes cultivation and use as 
food or feed, the VKM GMO Panel concludes that the comparative analysis of the newly 
synthesised anthocyanin pigments delphinidin, cyanidin and pelargonidin in its petals is 
sufficient for the risk assessment. The reported morphological differences between 
Moonvelvet IFD-26407-2 and its conventional carnation counterpart CW do not raise safety 
concerns. 
Food and feed risk assessment 
An in vitro mutagenicity test (Ames test) with Salmonella typhimurium has been performed 
by the applicant on aqueous extracts from leaves and petals from carnation Moonvelvet IFD-
26407-2. The test did not reveal adverse effects of the extracts. The CYTB5, F3’5’H and ALS 
proteins do not show sequence resemblance to known toxins or IgE-dependent allergens, 
nor have they been reported to cause IgE-mediated allergic reactions. The anthocyanins 
delphinidin and cyanidin expressed as a result of the genetic modification are normally 
present in numerous plant foods and are authorised as food additives.  
Based on current knowledge, information supplied by the applicant, and considering the 
intended use, which excludes cultivation and use as food and feed, the VKM GMO Panel 
concludes that carnation Moonvelvet IFD-26407-2 is as safe as its conventional counterpart, 
carnation CW. It is unlikely that the CYTB5, F3’5’H or ALS proteins, or the delphinidin or 
cyanidin pigments, will introduce a toxic or allergenic potential in carnation Moonvelvet IFD-
26407-2. 
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Environmental assessment 
Considering the intended use of Moonvelvet IFD-26407-2, which excludes cultivation and use 
as food or feed, the environmental risk assessment is concerned with accidental release into 
the environment of viable seeds/pollen, and rooted plants during transportation and 
distribution. 
With the exception of herbicide-tolerance, Moonvelvet IFD-26407-2 has no altered survival, 
multiplication or dissemination characteristics compared to conventional carnation cultivars, 
and there are no indications of an increased likelihood of spread and establishment of feral 
carnation plants in the case of accidental release into the environment. Carnations are 
cultivated in Norway but plant to plant gene flow is not considered to be an issue due to low 
pollen spread and viability and low likelihood of seed development from cut flowers. 
Based on current knowledge and considering its import, distribution and intended use as cut 
ornamental flowers, the VKM GMO Panel concludes that carnation Moonvelvet IFD-26407-2 
does not represent an environmental risk in Norway. 
Post-market environmental monitoring 
The objectives of a monitoring plan according to Annex VII of Directive 2001/18/EC are to 
confirm that any assumption regarding the occurrence and impact of potential adverse 
effects of the GMO, or its use, in the environmental risk assessment are correct and to 
identify the occurrence of adverse effects of the GMO, or its use, on human health or the 
environment which were not anticipated in the environmental risk assessment. 
Based on current knowledge and considering its import, distribution and intended use as cut 
ornamental flowers, the VKM GMO Panel concludes that the environmental risk assessment 
did not identify any potential adverse environmental effects of the transgenic line of 
carnation Moonvelvet IFD-26407-2. Thus, the general post-market surveillance plan is 
sufficient and there is no need for a specific post-market surveillance plan. 
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Overall conclusion 
Considering that carnation Moonvelvet IFD-26407-2 is not intended for cultivation or use as 
food or feed, the VKM GMO Panel considers that the comparative analysis of the newly 
synthesised anthocyanin pigments delphinidin, cyanidin and pelargonidin in its petals is 
sufficient for the risk assessment. The reported morphological differences between 
Moonvelvet IFD-26407-2 and its conventional carnation counterpart Cerise Westpearl (CW) 
do not raise safety concerns.  
Based on current knowledge, information supplied by the applicant, and considering the 
intended use, which excludes cultivation and use as food and feed, the VKM GMO Panel 
concludes that Moonvelvet IFD-26407-2 is as safe as its conventional counterpart CW. It is 
unlikely that the CYTB5, F3’5’H or ALS proteins, or the delphinidin or cyanidin pigments, will 
introduce a toxic or allergenic potential in carnation Moonvelvet IFD-26407-2. 
Likewise, the VKM GMO Panel concludes that carnation Moonvelvet IFD-26407-2, based on 
current knowledge, and intended use as cut flowers, does not represent an environmental 
risk in Norway. 
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 Sammendrag på norsk 
Som en del av forberedelsene til implementering av EU-forordning 1829/2003 i norsk rett, er 
Vitenskapskomiteen for mattrygghet (VKM) bedt av Miljødirektoratet (tidligere Direktoratet 
for naturforvalting [DN]) og Mattilsynet om å utarbeide endelige helse- og 
miljørisikovurderinger av alle genmodifiserte organismer (GMOer) og avledete produkter som 
inneholder eller består av GMOer som er godkjent under forordning 1829/2003 eller direktiv 
2001/18, og som er godkjent for ett eller flere bruksområder som omfattes av 
genteknologiloven. Miljødirektoratet og Mattilsynet har bedt VKM om endelige 
risikovurderinger for de EU-godkjente søknader hvor VKM ikke har avgitt endelige 
risikovurderinger. I tillegg er VKM bedt om å vurdere hvorvidt det er nødvendig med 
oppdatering eller annen endring av de endelige helse- og miljørisikovurderingene som VKM 
tidligere har levert. 
Den genmodifiserte, nellik (Dianthus caryophyllus L.) linjen IFD-26407-2 (unik kode IFD-
264Ø7-2; produktnavn Moonvelvet™) fra Florigene ble godkjent til import og salg som 
avskårne prydblomster under EUs utsettingsdirektiv 2001/18/EC den 24.4.2015 (jfr. 
Kommisjonsbeslutning 2015/694). Søknad C/NL/09/02 omfatter nellikplanter som er 
produsert ved vegetativ formering, og omfatter ikke avledete sorter fra konvensjonelle 
kryssinger med Moonvelvet IFD-26407-2.  En betingelse for salg er en etikett eller et 
dokument som følger produktet der det skal spesifiseres at det er genmodifisert og ordene 
«not for human or animal consumption nor for cultivation» (ikke for konsum eller for 
dyrking). 
VKM har ikke tidligere uttalt seg om genmodifisert nelliklinje Moonvelvet IFD-26407-2.  
Risikovurderingen av den genmodifiserte nelliklinjen er basert på søkers dokumentasjon og 
uavhengige vitenskapelige publikasjoner, samt vitenskapelige vurderinger og kommentarer 
fra EFSA (EFSA, 2014b) og andre medlemstater som er gjort tilgjengelig på EFSAs nettside 
EFSA GMO Extranet. Bortsett fra gjennomgang av nylig offentliggjort publikasjoner er resten 
av teksten i denne vurderingen en oppsummering av tidligere EFSA (EFSA, 2014b) 
vurderingen, som er vedlagt i Appendix I. For utfyllende detaljer henvises leserne til det. 
Vurderingen er gjort i henhold til tiltenkt bruk i EU/EØS-området, og i overensstemmelse 
med Matloven, miljøkravene i Genteknologiloven med forskrifter, først og fremst forskrift om 
konsekvensutredning etter Genteknologiloven. Videre er kravene i EU-forordning 
1829/2003/EF, utsettingsdirektiv 2001/18/EF (vedlegg 2, 3 og 3B) og veiledende notat til 
Annex II (2002/623/EF), samt prinsippene i EFSAs retningslinjer for risikovurdering av 
genmodifiserte planter og avledete næringsmidler (EFSA, 2006a; EFSA, 2009a; EFSA, 2010a; 
EFSA, 2011a; EFSA, 2011b; EFSA, 2011c) lagt til grunn for vurderingen.  
Den vitenskapelige vurderingen omfatter transformeringsmetoden og vektorkonstruksjonen, 
karakterisering og nedarving av genkonstruksjonen, komparativ analyse av antocyanin 
innhold i kronbladene og andre morfologiske egenskaper, kritiske toksiner,  allergener og 
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nye proteiner. Videre er potensiale for utilsiktede effekter på fitness, genoverføring til 
målorganismer og ikke-målorganismer, og biogeokjemiske prosesser vurdert. 
Det presiseres at VKMs mandat ikke omfatter vurderinger av etikk, bærekraft og 
samfunnsnytte, i henhold til kravene i den norske genteknologiloven og dens 
konsekvensutredningsforskrift. Disse aspektene blir derfor ikke vurdert av VKMs faggruppe 
for genmodifiserte organismer. Vurderinger av mulige plantevernmiddelrester i den 
genmodifiserte planten som følge av endret sprøytemiddelbruk faller per i dag utenfor VKMs 
ansvarsområde og er derfor heller ikke vurdert.  
Nellik Moonvelvet IFD-26407-2 uttrykker tre nye egenskaper: cytb5 -genet som koder for 
cytokrom b5 (CYTB5) og f3′5′h-genet som koder for flavonol 3′,5′- hydroksylase (F3′5′H); 
begge stammer fra Petunia x hybrida. Disse pigmentgener fører til endringen i produksjonen 
av antocyanin pigmenter i kronbladene, med fargeendring i blomsten som resultat. I tillegg, 
inneholder nellik Moonvelvet IFD-26407-2 et mutert als (SuRB) gen fra Nicotiana tabacum 
som koder for en variant av acetolactatsyntase (ALS)-enzymet. De transgene plantene vil 
derfor tolerere høyere doser av ALS-inhiberende herbicider som klorimuron, tifensulfuron og 
sulfonylureaer og brukes for identifikasjon av transformerte GM planter. 
Molekylær karakterisering 
Den molekylære karakteriseringen fra søker viser at nelliken Moonvelvet IFD-26407-2 
inneholder en fullstendig kopi av det transgene innskudds-DNAet (T-DNA) fra 
transformasjonsvektoren pCGP2355. T-DNAet består blant annet av én kopi for hver av de 
tre genene f3′5′h, cytb5 og als. Southern blot og PCR -analyser indikerer ingen overføring av 
vektorsekvenser utenfor området til T-DNA, og ytterligere sekvensanalyser viser ingen tegn 
til at endogene gener har blitt brutt. Databasesøk utført av søker viste ingen relevante 
samsvar mellom antatte genprodukt fra de innsatte genene eller nye tilførte åpne 
leserammer (ORFs), og kjente toksiner. Søkene viste derimot en partiell likhet (~35%) 
mellom ALS proteinet og et kjent allergen. Liknende treff (~35% samsvar) ble også 
observert for eventuelle genprodukt fra to av de nye åpne leserammene. De observerte 
partielle likhetene til kjente allergener anses ikke som vesentlige. Uttrykk av de tre genene 
f3′5′h, cytb5 og als i kronblader er vist ved Northern blot analyse. Produksjonen av 
fungerende F3’5’H og Cytb5 – enzymer, og delphinidin-basert pigmenter i Moonvelvet IFD-
26407-2 fremkom av blomsterfargen, og analyser med både tynnsjiktkromatografi (TLC) og 
væskekromatografi (HPLC). I kronblader ble delphinidin målt til 2,87 mg/g ferskvekt. 
Toleranse for sulfonylurea-herbicid viste tilstedeværelse av aktivt ALS-protein. Ved dyrking 
av Moonvelvet IFD-26407-2 har det så langt ikke blitt rapportert om relevante avvik ved den 
introduserte blomsterfargen, hvilket indikerer genetisk stabilitet. 
Basert på dagens kunnskap og informasjonen fra søker, konkluderer VKMs faggruppe for 
GMO, at den molekylære karakteriseringen ikke tilsier noen økt risiko ved nellik Moonvelvet 
IFD-26407-2 sammenliknet med konvensjonelle nelliksorter. 
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Komparative analyser 
Med hensyn til tiltenkt bruksområde som ekskluderer dyrking og bruk i mat og fôr, og fordi 
innhold av næringsstoffer, antinæringsstoffer og andre biologisk aktive komponenter i 
konvensjonelle nelliker er ukjent, ble kun innhold av de tre antocyanin pigmentene delfinidin, 
cyanidin and pelargonidin i kronblader fra Moonvelvet IFD-26407-2 rapportert av søker. 
Sammenlignet med den konvensjonelle motpart nellik Cerise Westpearl (CW) inneholder 
kronbladene fra nellik Moonvelvet IFD-26507-2 høyere nivåer av delfinidin og cyanidin, mens 
nivået av pelargonidin var lavere. Dette bekreftet de tilsiktede effektene av 
genmodifiseringen. Morfologiske egenskaper ble også rapportert fra feltforsøk og avslørte at 
i tillegg til endret kronbladfarge var det variasjon mellom nelliktypene i ti egenskaper. Ingen 
av de rapporterte forskjellene i sammensetning eller morfologiske egenskaper er forventet å 
ha innvirkning på risikoscenarier ved utilsiktet miljøeksponering eller inntak av nellik 
Moonvelvet IFD-26407-2. 
Ut i fra dagens kunnskap og informasjon tilsendt av søker, og tatt i betraktning tiltenkt 
bruksområde som ekskluderer dyrking og bruk i mat og fôr, konkluderer VKMs faggruppe for 
GMO at de komparative analysene som er begrenset til de nysyntetiserte anthocyanin 
pigmentene delfinidin, cyanidin og pelargonidin i kronbladene er tilstrekkelig for 
risikovurderingen. De rapporterte morfologiske forskjellene mellom Moonvelvet IFD-26407-2 
og dens konvensjonelle motpart nellik CW medfører ikke en økt sikkerhetsrisiko. 
Helserisiko 
En in vitro mutagenisitetsstudie (Ames test) har blitt utført av søker hvor ekstrakter av 
kronblad og blomsterblad fra Moonvelvet IFD-26507-2 ble testet på bakterien Salmonella 
typhimurium. Studien viste ingen negative effekter av ekstraktene. Proteinene CYTB5, F3′5′H 
og ALS har ingen relevante sekvenslikheter med kjente toksiner eller IgE-avhengige 
allergener, og er heller ikke rapportert å ha forårsaket IgE-medierte allergiske reaksjoner. 
Antocyaninene delfinidin og cyanidin, uttrykt som et resultat av genmodifiseringen er normalt 
til stede i mange frukt og grønnsaker og er godkjente tilsetningsstoffer i mat.  
Ut i fra dagens kunnskap, informasjon tilsendt av søker, og tatt i betraktning tiltenkt 
bruksområde som ekskluderer dyrking og bruk i mat og fôr, konkluderer VKMs faggruppe for 
GMO at Moonvelvet IFD-26407-2 er like trygg som dens konvensjonelle motpart, nellik CW. 
Det er usannsynlig at CYTB5, F3’5’H eller ALS proteinene, eller delfinidin eller cyanidin 
pigmentene, vil føre til et toksisk eller allergent potensiale i Moonvelvet IFD-26507-2. 
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Miljørisiko 
Miljørisikovurderingen av nelliklinjen Moonvelvet IFD-26407-2 er avgrenset til mulige effekter 
av utilsiktet spredning av pollen og spiredyktige frø i forbindelse med transport og bruk som 
avskårne prydblomster. Faggruppen har ikke vurdert mulige miljøeffekter knyttet til dyrking 
av nelliklinjen.  
Med unntak av herbicidtoleranse har genmodifiseringen av nelliklinjen Moonvelvet IFD-
26407-2 ikke medført endringer i egenskaper knyttet til overlevelse, oppformering eller 
spredning sammenlignet med konvensjonell nellik, og det er ingen indikasjoner på økt 
sannsynlighet for spredning og etablering av viltvoksende nellikplanter fra utilsiktet frøspill av 
nelliklinjen. Hagenellik dyrkes i Norge, men det er lite risiko for spredning av gener grunnet 
manglende mulighet og tid for pollen- og frøutvikling i de avskårne blomstene. Det er derfor 
ikke risiko for utkrysning med dyrkede sorter, ville planter eller andre organismer i Norge. 
Ut i fra dagens kunnskap og med bakgrunn i tiltenkt import, distribusjon og bruksområde 
som avskårne prydblomster, konkluderer VKMs faggruppe for GMO at nelliken Moonvelvet 
IFD-26407-2 ikke vil medføre en miljørisiko i Norge.  
Samlet vurdering 
Tatt i betraktning tiltenkt bruksområde som ekskluderer dyrking og bruk i mat og fôr, 
konkluderer VKMs faggruppe for GMO at den komparative analysen begrenset til de 
nysyntetiserte antocyaninpigmentene delfinidin, cyanidin og pelargonidin i kronbladene til 
nellik Moonvelvet IFD-26407-2 er tilstrekkelig for risikovurderingen. De rapporterte 
morfologiske forskjellene mellom Moonvelvet IFD-26407-2 og dens konvensjonelle motpart 
nellik Cerise Westpearl (CW) medfører ikke en økt sikkerhetsrisiko.  
Ut i fra dagens kunnskap og informasjon tilsendt av søker, og tatt i betraktning tiltenkt 
bruksområde som ekskluderer dyrking og bruk som mat og fôr, konkluderer VKM’s GMO 
Panel at Moonvelvet IFD-26407-2 er like trygg som dens konvensjonelle motpart. Det er 
usannsynlig at CYTB5, F3’5’H eller ALS proteinene, eller delfinidin eller cyanidin pigmentene 
vil medføre et toksisk eller allergent potensiale i Moonvelvet IFD-26407-2. 
Likeledes finner faggruppen, ut i fra dagens kunnskap, at den omsøkte bruken av 
Moonvelvet IFD-26407-2 som avskårne prydblomster ikke vil medføre en miljørisiko i Norge.  
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 Abbreviations and glossary 
ALS Acetolactate synthase 
CW Cerise Westpearl 
CYTB5 Cytochrome b5 
DNA Deoxyribonucleic acid 
EC European Commission 
EFSA European Food Safety Authority 
ERA Environmental risk assessment 
EU European Union 
F3’5’H Flavonoid 3′,5′-hydroxylase  
Fitness Describes an individual's ability to reproduce successfully relative to 
that of other members of its population. 
GM Genetically modified  
GMO Genetically modified organisms 
GMP Genetically modified plants 
mRNA Messenger RNA 
MS Member states 
MT/NFSA Norwegian Food Safety Authority (Mattilsynet) 
OECD Organisation for Economic Co-operation and Development 
PCR Polymerase chain reaction, a technique to amplify DNA by copying 
PMEM Post-market environmental monitoring 
VKM Norwegian Scientific Committee for Food Safety 
(Vitenskapskomiteen for mattrygghet) 
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 Background 
In March 2009, an application (Reference C/NL/09/02) covering import of cut flowers of the 
genetically modified carnation Moonvelvet IFD-26407-2 (Unique Identifier IFD-26Ø7-2) for 
ornamental use was submitted by Florigene Ltd. to the competent authority of the 
Netherlands. The scope of the application was restricted to flowers produced by vegetative 
propagation, and did not cover progeny derived from sexual crosses with the Moonvelvet 
IFD-26407-2 cultivar. 
In July 2009, the European Commission received the full application and an assessment 
report from the Netherlands.  In accordance with Directive 2001/18/EC (EC, 2001), the 
application was transmitted to the competent authorities of the other Member States for a 
60-day public hearing.  
The EFSA GMO Panel published its scientific opinion on application C/NL/09/02 12 December 
2014 (EFSA, 2014b), and carnation Moonvelvet IFD-26407-2 was approved for import and 
ornamental use 24 April 2015 (Commission Decision 2015/694). A condition for placing on 
the market is a label or document accompanying the product that states that carnation 
Moonvelvet IFD-26407-2 is genetically modified and “not for human or animal consumption 
nor for cultivation”.  
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 Terms of reference  
The Norwegian Environment Agency (formerly the Norwegian Directorate for Nature 
Management) has the overall responsibility for processing applications for the deliberate 
release of genetically modified organisms (GMOs). This entails inter alia coordinating the 
approval process, and to make a holistic assessment and recommendation to the Ministry of 
the Environment regarding the final authorisation process in Norway. The Agency is 
responsible for assessing environmental risks upon the deliberate release of GMOs, and to 
assess the product's impact on sustainability, benefit to society and ethics under the Gene 
Technology Act. 
The Norwegian Food Safety Authority (NFSA) is responsible for assessing risks to human and 
animal health upon the deliberate release of GMOs pursuant to the Gene Technology Act and 
the Food Safety Act. In addition, NFSA administers the legislation for processed products 
derived from GMO and the impact assessment on Norwegian agriculture according to sector 
legislation. 
The Norwegian Environment Agency 
In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian 
Environment Agency, by letter dated 13 June 2012 (ref. 2008/4367/ART-BI-BRH), requests 
VKM, to conduct final environmental risk assessments for all genetically modified organisms 
(GMOs) and products containing or consisting of GMOs that are authorised in the European 
Union under Directive 2001/18/EC or Regulation 1829/2003/EC. The request covers scope(s) 
relevant to the Gene Technology Act. 
The Norwegian Environmental Agency has also requested VKM, by letter dated 19 May 2015 
(ref. 2015/4151), to conduct a final environmental risk assessment of genetically modified 
carnation Moonvelvet IFD-26407-2 for import of cut flowers for ornamental use (Application 
C/NL/09/02). 
The request does not cover GMOs that VKM already has conducted its final risk assessments 
on. However, the Norwegian Environment Agency requests VKM to consider whether 
updates or other changes to earlier submitted assessments are necessary. 
The basis for evaluating the applicants’ environmental risk assessments is embodied in the 
Act Relating to the Production and Use of Genetically Modified Organisms etc. (the 
Norwegian Gene Technology Act), Regulations relating to impact assessment pursuant to the 
Gene Technology Act, the Directive 2001/18/EC on the deliberate release of genetically 
modified organisms into the environment, Guidance note in Annex II of the Directive 
2001/18 (2002/623/EC) and the Regulation 1829/2003/EC. In addition, the EFSA guidance 
documents on risk assessment of genetically modified plants and food and feed from the GM 
plants (EFSA, 2010a; EFSA, 2011b), the risk assessment of GM plants used for non-
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food/feed purposes (EFSA, 2009a) and OECD guidelines will be useful tools in the 
preparation of the Norwegian risk assessments. 
The risk assessments’ primary geographical focus should be Norway, and the risk 
assessments should include the potential environmental risks of the product(s) related to any 
changes in agricultural practices. The assignment covers assessment of direct environmental 
impact of the intended use of pesticides with the GMO under Norwegian conditions, as well 
as changes to agronomy and possible long-term changes in the use of pesticides. 
The Norwegian Food Safety Authority  
In preparation for a legal implementation of EU-regulation 1829/2003, the Norwegian 
Environment Agency has requested NFSA to give final opinions on all GMOs and products 
containing or consisting of GMOs that are authorised in the European Union under Directive 
2001/18/EC or Regulation 1829/2003/EC within the Authority’s sectoral responsibility. The 
request covers scope(s) relevant to the Gene Technology Act.  
NFSA has therefore, by letter dated 13 February 2013 (ref. 2012/150202), requested VKM to 
carry out final scientific risk assessments of 39 GMOs and products containing or consisting 
of GMOs that are authorised in the European Union.  
NFSA has also requested VKM, by letter dated 26 August 2015 (ref. 2015/176539), to 
conduct a final risk assessment of carnation Moonvelvet IFD-26407-2 for import of cut 
flowers for ornamental use (Application C/NL/09/02). 
The assignment from NFSA includes food and feed safety assessments of GMOs and their 
derivatives, including processed non-germinating products, intended for use as or in food or 
feed.  
In the case of submissions regarding genetically modified plants (GMPs) that are relevant for 
cultivation in Norway, VKM is also requested to evaluate the potential risks of GMPs to the 
Norwegian agriculture and/or environment. Depending on the intended use of the GMP(s), 
the environmental risk assessment should be related to import, transport, refinement, 
processing and cultivation. If the submission seeks to approve the GMP(s) for cultivation, 
VKM is requested to evaluate the potential environmental risks of implementing the plant(s) 
in Norwegian agriculture compared to existing varieties (e.g. consequences of new genetic 
traits, altered use of pesticides and tillage). The assignment covers both direct and 
secondary effects of altered cultivating practices.  
VKM is further requested to assess risks concerning coexistence of cultivars. The assessment 
should cover potential gene flow from the GMP(s) to conventional and organic crops as well 
as to compatible wild relatives in semi-natural or natural habitats. The potential for 
establishment of volunteer populations within the agricultural production systems should also 
be considered. VKM is also requested to evaluate relevant segregation measures to secure 
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coexistence during agricultural operations up to harvesting. Post-harvest operations, 
transport and storage are not included in the assignment.  
Evaluations of suggested measures for post-market environmental monitoring provided by 
the applicant, case-specific monitoring and general surveillance, are not covered by the 
assignment from NFSA. In addition, the changes related to herbicide residues of GMPs as a 
result of the application of plant-protection products fall outside the remit of the Norwegian 
VKM Panel. 
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 Assessment 
1 Introduction 
Carnation Moonvelvet IFD-26407-2 from Florigene Ltd. is a genetically modified (GM) cultivar 
of Dianthus caryophyllus L. intended for import, distribution and retail in the European Union 
as cut flowers for ornamental use only. This draft opinion is to a large extent a summary of 
the previous scientific opinion by (EFSA, 2014b), reports/comments from other member 
states made available on the EFSA website GMO Extranet and relevant peer-reviewed 
scientific literature. The VKM GMO Panel has not previously published a risk assessment of 
carnation Moonvelvet IFD-26407-2. The above-mentioned EFSA report is provided in 
Appendix I, and readers are referred to this for details. The assessment was performed in 
accordance with principles of guidance documents on risk assessment of GM plants for non-
food and non-feed purposes (EFSA, 2009a) and on the environmental risk assessment of GM 
plants (EFSA, 2010a). Furthermore, the EFSA GMO Panel based its evaluation of carnation 
Moonvelvet IFD-26407-2 (EFSA, 2014b) on experience gained from previously assessing GM 
carnations with similar traits (EFSA, 2006b; EFSA, 2008) as well as considering the safety for 
humans in view of possible exposure routes through dermal contact, inhalation, and oral 
intake. 
Carnation Moonvelvet IFD-26407-2 was developed for petal colour for decorative purposes. 
The expression of the newly introduced genes, cytb5 and f3′5′h, both from Petunia × 
hybrida, coding for cytochrome b5 (CYTB5) and flavonoid 3′,5′-hydroxylase (F3′5′H) 
respectively, confers the violet/blue colour to the flowers. Biosynthesis of anthocyanin 
pigments cyanidin and delphinidin in the petals is enabled via interplay between introduced 
and endogenous genes in the anthocyanin biosynthesis pathway. In addition, carnation 
Moonvelvet IFD-26407-2 expresses herbicide tolerance by the introduction of a mutated als 
gene from the SuRB locus of Nicotiana tabacum coding for an acetolactate synthase (ALS) 
variant protein, used to facilitate the selection of successfully modified shoots during the 
genetic transformation process. 
Anthocyanins are widely distributed in nature. Cyanidin and delphinidin are among the most 
common of a class of about 100 water soluble pigments with common biosynthetic origins. 
These glycosides are naturally formed by anthocyanidins and various sugars. They are stably 
localized in plant organs, such as petals, and are red, purple, blue, and black (Zhao and Tao, 
2015). Cyanidin and delphinidin are naturally present in foods like aubergines, blueberries 
and blackcurrants at relatively high levels. Studies have shown that colour differences are 
related to the types and amounts of anthocyanin present. Pink flowers contain cyanidin 
aglycone and pelargonidin aglycone as the core anthocyanins, and purple flowers contain 
mainly delphinidin aglycone and cyanidin aglycone as the core anthocyanins (Zhao and Tao, 
2015).  
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The acetolactate synthase (ALS) enzyme is present in all plant species and catalyses the 
biosynthesis of branched amino acids (reviewed in (Chandler et al., 2013). ALS-inhibiting 
herbicides, such as chlorimuron, thifensulfuron and sulfonylureas, cause growth retardation 
in seedlings by impairing branch chain amino acid synthesis in treated grasses and broadleaf 
weeds, but not in crops such as rice, wheat, barley, soybean, maize and others due to their 
high endogenous ALS expression. The herbicides have potency at extremely low 
concentrations, but rapid resistance development in weeds has limited their application (see 
review by (Tranel and Wright, 2002). However, the introduction of the mutated als gene 
(SuRB) in carnation Moonvelvet IFD-26407-2 with resulting tolerance to sulfonylurea 
herbicides was not primarily intended for plant protection purposes, but rather used as a 
marker trait for the selection of successfully transformed plants. 
Carnation Moonvelvet IFD-26407-2 has been currently evaluated by the VKM GMO Panel 
with reference to its intended uses in the European Economic Area (EEA), and according to 
the principles described in the Norwegian Food Act, the Norwegian Gene Technology Act and 
regulations relating to impact assessment pursuant to the Gene Technology Act, Directive 
2001/18/EC on the deliberate release into the environment of genetically modified 
organisms, and Regulation (EC) No 1829/2003 on genetically modified food and feed. 
VKM has also taken into account the appropriate principles described in the EFSA guideline 
on the risk assessment of GM plants used for non-food/feed purposes (EFSA, 2009a), the 
risk assessment of GM plants and derived food and feed (EFSA, 2011b), the environmental 
risk assessment of GM plants (EFSA, 2010), the selection of comparators for the risk 
assessment of GM plants (EFSA, 2011a), and for the post-market environmental monitoring 
of GM plants (EFSA, 2011c). 
It is emphasised that the VKM mandate does not include assessments of contribution to 
sustainable development, societal utility or ethical considerations, according to the 
Norwegian Gene Technology Act and Regulations relating to impact assessment pursuant to 
the Gene Technology Act. These considerations are therefore not part of the risk assessment 
provided by the VKM Panel on Genetically Modified Organisms.  
  
 
VKM Report 2015: 18  23 
 2 Molecular characterisation 
The EFSA GMO Panel (EFSA, 2014b in Appendix I) has previously assessed the molecular 
characterisation of the carnation event IFD-26407-2 (Moonvelvet; cytb5, f3’5’h and SuRB 
[mutated version of als] insert) with regards to the following: 
1. The transformation system and vector constructs 
2. Characterisation of the transgene insertions and constructs 
3. Analyses of new open reading frames (ORFs) 
4. Information on the expression of the insert including quantification of new 
metabolites 
5. Inheritance and stability of the inserted DNA 
The panel concluded that the applicant had provided sufficient analyses to characterise the 
DNA insert, number of inserts, integration site and flanking sequences in the carnation 
Moonvelvet IFD-26407-2 genome.  
Carnation variety Cerise Westpearl (CW) was transformed using disarmed Agrobacterium 
tumefaciens strain AGL0, which carried the transformation vector pCGP2355. The vector 
contained the following expression cassettes:  
1) the cytochrome b5 (cytb5) cassette, consisting of the promoter fragment from 
Antirrhinum majus chalcone synthase (CHS) gene, the cytb5 (difF) complementary DNA 
(cDNA) from Petunia × hybrida and the terminator sequence of a gene encoding a Petunia × 
hybrida putative phospholipid transfer protein homologue 
2) the flavonoid 3′,5′-hydroxylase (f3′5′h) cassette, consisting of a chimeric f3′5′h gene 
constructed from the Petunia × hybrida f3′5′h cDNA, and the promoter and terminator 
fragments of a Dianthus caryophyllus anthocyanidin synthase (ans) gene 
3) the acetolactate synthase cassette (als) from tobacco, conferring tolerance to sulfonylurea 
herbicides. The cassette contains the CaMV 35S promoter, the mutated als coding region 
and terminator sequence from Nicotiana tabacum  
Carnation Moonvelvet IFD-26407-2 contains one transgenic locus with a single full length 
transfer-DNA-sequence (T-DNA) from the transformation vector pCGP2355. Southern blot 
analyses indicate that there are intact single copies of each integrated component, including 
the three genes f3′5′h, cytb5 and als in the transferred T-DNA. Southern blot and 
polymerase chain reaction (PCR) analyses further indicated that no plasmid backbone 
sequences were integrated into carnation Moonvelvet IFD-26407-2. The sequences of the 
insert and the flanking regions were provided by the applicant. Bioinformatic analysis of the 
5′ and 3′ flanking regions did not reveal disruption of known endogenous genes. 
The putative translation products of open reading frames (ORFs) within the insert and 
spanning the junction sites were compared to known toxins and allergens in appropriate 
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databases. No relevant similarities were found for toxins. A higher than 35 % sequence 
identity was found however within the ALS protein to an allergen from Davidiella tassiana, 
when employing an 80-amino-acid long sliding window, looking for a minimum of 35% 
contiguous identical amino acids. Likewise an identity of more than 35% was found with the 
allergen ‘Amb a 4’ from the common ragweed Ambrosia artemisiifolia. When searches were 
done for sequences of eight contiguous amino acids, a positive match was also found with a 
subtilisin protease allergen in Bacillus licheniformis. Due to lack of essential regulatory 
factors the likelihood that any of the above mentioned open reading frames would be 
transcribed and translated in carnation Moonvelvet IFD-26407-2, is deemed negligible. 
Presence of transcripts corresponding to the f3′5′h, cytb5 and als genes in petals was 
examined by Northern blot analysis. The results showed hybridisation signals only in 
Moonvelvet, not in the parental line CW. Expression levels were not quantified. Activity of 
F3’5’H and Cytb5 enzymes and production of delphinidin was further indicated by the altered 
flower colour and metabolite analysis with both thin layer chromatography (TLC) and high-
pressure liquid chromatography (HPLC). The level of delphinidin in flowers of Moonvelvet 
IFD-26407-2 was approximately 2.87 mg/g fresh weight. Tolerance to sulfonylurea 
herbicides indicated the activity of the ALS protein.  
Carnation Moonvelvet IFD-26407-2 was propagated vegetatively from January 2005 to 
September 2008, which represents multiple cycles of propagation. During 2007–2013, plants 
were cultivated in a field trial in Colombia and there were no reported incidents of flower 
colour change that would indicate genetic instability.  
2.1 Conclusions 
Based on current knowledge and the information provided by the applicant, the VKM GMO 
panel concludes that the molecular characterisation of carnation Moonvelvet IFD-26407-2 
does not indicate a safety concern. 
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 3 Comparative assessments 
Previously, EFSA (EFSA, 2014b in Appendix I) assessed compositional and morphological 
data of carnation Moonvelvet IFD-26407-2 provided by the applicant. A brief summary from 
these reports are provided below. 
Since carnations have no or very limited history of use as food or feed, their content of 
nutrients, antinutritional factor and other components with biological activity is largely 
unknown. The import of carnation Moonvelvet IFD-26407-2 into the EU or Norway is not 
intended for food or feed use, nor for cultivation, and therefore components other than the 
anthocyanins delphinidin, cyanidin, petunidin and pelargonidin have not been analysed in 
carnation Moonvelvet IFD-26407-2 (EFSA, 2014b) or other GM carnations (EFSA, 2006b; 
EFSA, 2008; EFSA, 2014a). The comparative compositional assessment as defined in EFSA 
guidance documents for GM plants and derived food and feed (EFSA, 2006a) was therefore 
only partially applied and possible unintended effects of the genetic modification in carnation 
Moonvelvet IFD-26407-2 cannot be assessed. 
3.1 Production of material for comparative assessment 
The field trials conducted by the applicant, from which materials and morphological 
characteristics were gathered, were not described in detail. The VKM GMO Panel considers 
this a short-coming in the application and it makes a full assessment of the data difficult. 
However, since the carnation Moonvelvet IFD-36407-2 is not intended for cultivation or for 
use in food or feed, the documentation provided is most likely sufficient for the scope of the 
application. 
For the compositional studies, the three anthocyanins – delphinidin, cyanidin and 
pelargonidin – were analysed by HPLC in acetonitrile extracts of freeze-dried petals of 
carnation Moonvelvet IFD-26407-2 and its non-GM parental cultivar (conventional 
comparator; control) Cerise Westpearl (CW) according to the method described by Fukui et 
al. (2003). Carnation CW has cerise petals. The HPLC method included a hydrolysis step, 
which converted the pigments into their aglycones, allowing the determination of total 
delphinidin, total cyanidin and total pelargonidin, rather than as they occur in planta as 
glycosylated and/or acylated compounds. 
For assessment of morphological traits, carnation Moonvelvet IFD-26407-2 and its non-GM 
conventional comparator CW were grown in a field trial in Australia during the 2007-2008 
season.  
3.2 Compositional analysis 
HPLC data (Technical dossier; Fukui et al., 2003) indicated that compared to its non-GM 
parental cultivar Cerise Westpearl, carnation Moonvelvet IFD-26407-2 petals contained 
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higher levels of delphinidin and cyanidin and lower levels of pelargonidin (see Table 3.2-1). 
In other plant tissues, delphinidin-based pigments were not observed (stem, nodes, leaves 
and roots) or detected (leaves and roots) in carnation Moonvelvet IFD-26407-2. 
Table 3.2-1. Mean levels of the various anthocyanins reported in petals from GM and respective non-
GM comparator carnations. Values are mg pigment per g fresh weight (fw). 
Cultivar Delphinidin Cyanidin Pelargonidin 
Cerise Westpearl 
(CW)  
nd 0.01 1.06 
Moonvelvet 
IFD-26407-2  
2.87 0.37 0.01 
 
EFSA (EFSA, 2014b) concluded that the altered levels and types of anthocyanins in carnation 
Moonvelvet IFD-26407-2 accounted for the intended morphological changes in petal colour. 
Reported differences in anthocyanin content were not expected to influence the risk scenario 
upon accidental release to the environment or intake of the GM carnation. 
3.3 Morphological traits and GM phenotype 
According to the applicant, carnation Moonvelvet IFD-26407-2 has been evaluated in field 
trials in Australia during the 2007-2008 growing season. In total, 18 morphological 
characteristics most relevant to potential gene dispersal were analysed in carnation 
Moonvelvet IFD-26407-2 and its conventional comparator (cultivar CW), including stem 
length, leaf length and width, bud shape, flower diameter and fragrance, number of petals, 
number of styles, and the height of the calyx and corolla. An analysis of variance (ANOVA) 
identified eight significant differences between carnation Moonvelvet IFD-26407-2 and its 
comparator CW. Carnation Moonvelvet IFD-26407-2 had a lower number of internodes per 
stem, a thinner stem at the fifth node, shorter leaves at the third node, an increased calyx 
diameter, longer styles, less viable anthers, more filaments and a reduced filament length. In 
addition, the average number of days to flowering was shorter in carnation Moonvelvet IFD-
26407-2 than in carnation CW: 131 and 146 days. 
EFSA (EFSA, 2014b) concluded that the differences reported for morphological traits were 
not expected to influence the risk scenario upon accidental release to the environment or 
intake of the GM carnation. 
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 3.4 Conclusion 
Based on current knowledge and information provided by the applicant, and considering the 
intended use of carnation Moonvelvet IFD-26407-2, which excludes cultivation and use as 
food or feed, the VKM GMO Panel concludes that the comparative analysis limited to the 
newly synthesised anthocyanin pigments delphinidin, cyanidin and pelargonidin in its petals 
is sufficient for the risk assessment. The reported morphological differences between 
Moonvelvet IFD-26407-2 and its conventional carnation counterpart CW do not raise safety 
concerns. 
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 4 Food and feed safety assessment 
4.1 Previous evaluations by the VKM GMO Panel and EFSA 
Carnation Moonvelvet IFD-26407-2 was recently assessed by EFSA (EFSA, 2014b in Appendix 
I) and no adverse effects for the use of GM carnations in relation to non-GM cultivars, was 
identified. 
4.2 Product description and intended uses 
The EU Commission Decision 2015/694/EC stipulates that a condition for placing carnation 
Moonvelvet IFD-26407-2 on the market is an accompanying label or document that states 
that it is genetically modified and the words “not for human or animal consumption nor for 
cultivation”. Yet the possibility of accidental intake of the Moonvelvet IFD-26407-2 cannot be 
excluded. Therefore, the VKM GMO Panel has followed principles used in the safety 
assessment of food and feed derived from GMOs, as described in EFSA’s guidelines (EFSA, 
2011b), in the current safety assessment of carnation Moonvelvet IFD-26407-2. 
The scope of the application C/NL/09/02 is restricted to the import of cut carnations for 
ornamental use only. As is the case for the non-GM carnations, the petals of GM carnations 
are highly unlikely to be processed and used as food and feed. Thus, the stability of GM 
carnations during processing is not considered as an issue. 
4.3 Toxicological assessment  
 Toxicological assessment of newly expressed proteins 4.3.1
Bioinformatics analyses of the amino acid sequences of the newly expressed proteins in 
carnation Moonvelvet IFD-26407-2 do not show sequence resemblance to known toxins or 
IgE-dependent allergens, nor have they been reported to cause IgE-mediated allergic 
reactions. 
Other safety assessments of the ALS and F3’5’H proteins have not identified reason for 
concern (EFSA, 2006b; EFSA, 2008; EFSA, 2014a; EFSA, 2014b; VKM, 2008). 
 Toxicological assessment of new constituents other than proteins 4.3.2
The anthocyanins, cyanidin and delphinidin are naturally present in foods like aubergines, 
blueberries and blackcurrants at rather higher levels than in the petals of carnation 
Moonvelvet IFD-26407-2 (Cacho et al., 1992). Notably, anthocyanins (E 163) are authorised 
food additives according to regulation 1333/2008 (Reference EC No. 1333/2008), on food 
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additives. Previous evaluations of anthocyanins prepared by physical processes from natural 
foods identified no reason for concern or adverse effects (EFSA, 2013).  
4.3.2.1  In vitro studies 
The applicant performed studies on gene mutagenicity, Ames test, employing Salmonella 
typhimurium exposed to aqueous extracts from petals and leaves of GM carnation 
Moonvelvet IFD-26407-2 and non-GM control CW carnations. No mutagenic activity was 
observed. 
4.3.2.2  Acute tox icity study  
Acute toxicity studies were not performed. 
 Toxicological assessment of the whole GM plant 4.3.3
Taking into account that carnation Moonvelvet IFD-26407-2 are not intended for human or 
animal consumption as food or feed but are intended for ornamental use only, the possible 
effects of the genetic modifications on human health in the case of accidental intake is 
considered according to the EFSA guideline on the risk assessment of GM plants used for 
non-food/feed purposes purposes (EFSA, 2009a). Considering the assessment of the newly 
expressed proteins (section 4.3.1) and of the new constituents cyanidin and delphinidin 
(section 4.3.2 and 4.4), no adverse effects were reported or considered likely. 
The applicant did not provide information from studies on the whole GM plant.  
 Allergenicity 4.3.4
The strategies used when assessing the potential allergenic risk focus on the characterisation 
of the source of the recombinant protein, the potential of the newly expressed protein to 
induce sensitisation or to elicit allergic reactions in already sensitised persons and whether 
the transformation may have altered the allergenic properties of the modified food. A 
weight-of-evidence approach is recommended, taking into account all of the information 
obtained with various test methods, since no single experimental method yields decisive 
evidence for allergenicity (Codex Alimentarius, 2003; EFSA, 2006a; EFSA, 2010b; EFSA, 
2011b). 
4.3.4.1  Assessment of allergenicity of the new ly expressed proteins 
No significant similarities to known allergens were identified via bioinformatics analyses of 
the amino acid sequence of the newly expressed proteins in carnation Moonvelvet IFD-
26407-2 using the criterion of more than 35 % identity in a segment of 80 or more amino 
acids (Codex Alimentarius, 2003). Additionally, the applicant performed analyses searching 
for matches of eight contiguous identical amino acid sequences between these newly 
expressed proteins and known allergens, which would confirm the outcome of the above-
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mentioned bioinformatic analyses. No such similarities to known allergens were revealed. 
Moreover, other safety assessments of the ALS and F3’5’H proteins have not identified 
reason for concern (EFSA, 2006b; EFSA, 2008; EFSA, 2014a; EFSA, 2014b; VKM, 2008). 
The ALS, CYTB5, F3’5’H proteins do not show sequence resemblance to known IgE-
dependent allergens, nor have they been reported to cause IgE-mediated allergic reactions. 
4.3.4.2  Assessment of allergenicity of the whole GM plant 
As stated earlier, carnation Moonvelvet IFD-26407-2 is not intended for food or feed 
purposes. Although dermal and respiratory allergies to carnations in workers handling cut 
flowers/carnations has been described (Cistero-Bahima et al., 2000; Sanchez-Fernandez et 
al., 2004; Sanchez-Guerrero et al., 1999; Stefanaki and Pitsios, 2008), the source of which 
appears to be multifaceted. These allergies appear to be caused by the flower, mites such as 
Tetranychus urticae infesting the carnations or a combination of the two. Notably, case 
reports of occupational allergies to carnations are rare. Interestingly, a case report of an 
individual with a respiratory allergy to carnations with no occupational exposure was 
published recently (Brinia et al., 2013). However, according to the applicant, no adverse 
allergenic reactions to GM carnation cut flowers used for ornamental purposes have been 
reported in the human populations handling the flowers. 
4.4 Nutritional assessment of GM food and feed 
Although carnation Moonvelvet IFD-26407-2 is intended for ornamental use only and not 
intended for human or animal consumption as food or feed, it is worth noting that 
ornamental plants may become popular as foodstuff species due to their intrinsic nutritional 
value, antioxidant capacity and attractive appearance (Mlcek and Rop, 2011). Flower species 
of Dianthus, Chrysanthemum and Viola have been found to possess high levels of mineral 
elements, with potassium being the most abundant element observed (Rop et al., 2012) and 
as such may be considered to have health benefits (Chandler et al., 2013). Thus, the 
possible use of carnation Moonvelvet IFD-26407-2 as food, dietary supplements or garnish 
(edible decoration) in food cannot be entirely ruled out. A need for a health risk assessment 
associated with such occasional consumption has therefore been suggested (Chandler et al., 
2013). Moreover, a recent evaluation suggested that the release of genetically modified 
carnation varieties that express f3′5′h gene and thereby delphinidin-based anthocyanins do 
not pose an increased risk of harm to human or animal health (Chandler et al., 2013). 
Additionally, as mentioned earlier in section 4.3.2, cyanidin- and delphinidin-based 
anthocyanins are naturally present in foods like blueberries, aubergines and blackcurrants, as 
well as some non-GM carnation cultivars and other edible flower petals,  at higher levels than 
in the petals of carnation Moonvelvet IFD-26407-2 (Cacho et al., 1992). According to 
regulation 1333/2008 (Reference EC No. 1333/2008) on food additives, anthocyanins (E 163) 
are authorised food additives. Previous evaluations of anthocyanins prepared by physical 
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processes from natural foods identified no adverse effects or reason for concern (EFSA, 
2013). 
Chemically, water-soluble anthocyanins are derived from anthocyanidins by adding sugars. 
Thus, an anthocyanin contains a colour component, e.g. delphinidin or cyanidin, and 1-2 
glycosides (sugar derivatives). The most important anthocyanidins in plants are delphinidin 
and cyanidin, the same anthocyanins found in Moonvelvet IFD-26407-2 petals, as well as 
pelargonidin, peonidin, petunidin and malvidin (Wu et al., 2006). 
In terms of theoretical anthocyanin exposure with the intake of petals from carnation 
Moonvelvet IFD-26407-2, a comparison to anthocyanin levels in other common foods is of 
value. The amount of total anthocyanins is especially high in many dark berries and has 
been reported to be 3.9-4.9 mg/g fresh weight in blueberries (Wu et al., 2006), 2.5-4.9 
mg/g in black currents (Rubinskiene et al., 2005; Wu et al., 2006) and 4.0-6.7 mg/g in 
crowberry (Empetrum nigrum ; Koskela et al., 2010).  
Wu et al. (2006) estimated a daily anthocyanin intake of 12.5 mg/day/person in the United 
States, in which cyanidin and delphinidin contributed 45 and 21%, respectively. EFSA (2013) 
estimated that the mean exposure of anthocyanins in adults ranges from 0.7 to 1.9 mg/kg 
body weight per day and high level exposure to be in the range of 1.1 and 3.8 mg/kg body 
weight per day. In 1982, JECFA (WHO/FAO Joint Expert Committee on Food Additives) 
established an ADI (acceptable daily intake) of 2.5 mg/kg body weight per day for 
anthocyanins from grapeskin (JECFA, 1982). 
Cyanidin 
In the petals of Moonvelvet IFD-26407-2, a cyanidin concentration of 0.37 mg/g was 
reported by the applicant. Cyanidin is also present in non-GM carnations that have red, pink 
and purple colours. The concentration of cyanidin in Moonvelvet IFD-26407-2 is considerably 
lower than the non-GM carnation cultivars that Florigene has used in its comparison. 
Cyanidin concentration in e.g. blueberries is in the range of 0.3-0.7 mg/g fresh weight (Wu 
et al., 2006). The cyanidin level observed in the petals of Moonvelvet IFD-26407-2 is 
therefore not considered to pose a health risk compared to the cyanidin concentration found 
in petals of some non-GM carnation cultivars, blueberries and estimated ADI. 
Delphinidin 
In the petals of Moonvelvet IFD-26407-2, a delphinidin concentration of 2.87 mg/g was 
reported by the applicant. Delphinidin is not a naturally occurring anthocyanidin in 
carnations. Delphinidin concentration in e.g. blueberries is in the range of 1.2-1.4 mg/g fresh 
weight (Wu et al., 2006). Thus, the delphinidin concentration in carnation Moonvelvet IFD-
26407-2 petals is higher than in blueberries, but is still not considered to pose a health risk 
when compared to estimated ADI.  
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 4.5 Conclusion 
An in vitro mutagenicity test (Ames test) with Salmonella typhimurium has been performed 
by the applicant on aqueous extracts from leaves and petals from carnation Moonvelvet IFD-
26407-2. The test did not reveal adverse effects of the extracts. The CYTB5, F3’5’H and ALS 
proteins do not show sequence resemblance to known toxins or IgE-dependent allergens, 
nor have they been reported to cause IgE-mediated allergic reactions. The anthocyanins 
delphinidin and cyanidin expressed as a result of the genetic modification are normally 
present in numerous plant foods and are authorised as food additives.  
Based on current knowledge, information supplied by the applicant, and considering the 
intended use, which excludes cultivation and use as food and feed, the VKM GMO Panel 
concludes that carnation Moonvelvet IFD-26407-2 is as safe as its conventional counterpart, 
carnation CW. It is unlikely that the CYTB5, F3’5’H or ALS proteins, or the delphinidin or 
cyanidin pigments, will introduce a toxic or allergenic potential in carnation Moonvelvet IFD-
26407-2. 
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 5 Environmental risk assessment  
5.1 Introduction 
This assessment applies to carnation line Moonvelvet IFD-26407-2 from Florigene Ltd, which 
has been transformed to modify the flower color and possesses a mutated herbicide 
resistance als gene (SuRB) for in vitro selection. 
The application of this line covers only import, distribution and retailing of cut flowers, and 
does not include either cultivation or use of carnation as food or feed. The product is 
imported and sold as cut flowers, and exposure of the environment to living transgenic 
plants is therefore low.  
The genus Carnation (Dianthus L.) contains approximately 300 annual, biannual and 
perennial species, native mainly to southern parts of Asia and Europe (OGTR, 2006). 
Dianthus-species are found in alpine regions of Europe and Asia, as well as coastal areas in 
Mediterranian and Europe. Dianthus deltoides L., D. armeria L., D. barbatus L. and D. 
superbus L. are native in Norway, and also  isolated plants of non-native species (D. 
carthusianorum L., D. chinesis L. and D. plumarius L.) are reported from Norway (Lid and 
Lid, 2005). Carnations have been cultivated for more than 2000 years and extensive 
selection and breeding has resulted in thousands of commercial cultivars. They have been 
grown in Scandinavia as an ornamental species since the middle ages 
(http://www.plantearven.no). Wild populations of D. caryophyllus are only known from 
Greece, Italy, Sicily and Sardinia (Tutin and Walters, 1993). In this assessment, the term 
carnation is used for D. caryophyllus. 
Carnations are grown in Norway as an annual ornamental plant for outdoor gardens. 
Cultivars used in Norway are frost sensitive and do not survive in regions with temperatures 
lower than -5°C. There is no greenhouse production of carnation for cut flowers in Norway. 
Thus, all the cut flowers of carnation are imported. According to Statistics Norway import of 
carnation in 2014 was about 427 metric tonnes (www.sbb.no). 
Wild D. caryophyllus L. has simple, bisexual open flowers with five petals. Many of the 
carnation species are self-sterile. Selection and breeding has increased flower size, number 
of petals, and stem length as well as disease resistance (OGTR, 2006). In the modern 
cultivars, most of the stamens have been converted to petals (between 30 and 100 petals) 
and the stamens and carpels are completely surrounded by the petals.  Carnation cultivars 
are vegetatively propagated (Zuker et al., 2002).  
Cultivated carnations normally produce very little pollen. As the pollen viability is also low, 
seed setting is very low or completely absent (Galbally and Galbally, 1997). Pollen develops 
before the pistils are receptive for pollination. The pollen is heavy and sticky and it is not 
spread by wind. Insect pollination occurs in wild carnations, mainly by Lepidoptera species 
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(OGTR, 2006). Insect pollination of D. caryophyllus is difficult due to the morphology of the 
flower, and there are no known reports on insect pollination of cultivated D. caryophyllus 
(OGTR, 2006). Hand pollination is needed for sufficient seed set (Bird, 1994). Inbreeding 
depression appears already in the third generation and production of F1-hybrids is not a 
useful approach (Sato et al., 2000). Seed development takes about five weeks from 
pollination. Vase life of carnation can be up to two weeks. Thus, even if the flowers were 
pollinated, cut flowers will not be able to produce ripe seed. 
Commercially carnation is propagated either by cuttings or by tissue various culture methods 
in vitro. Carnation is perennial, but it does not produce stolons, rhizomes or other vegetative 
propagation units and it is not able to propagate spontaneously. Short side shoots are used 
as cuttings, which are rooted after a hormone treatment in greenhouse under proper 
temperature and high humidity. For propagation by tissue culture, appropriate laboratory 
facilities are needed.  
5.2 Unintended effects on plant fitness due to the genetic 
modifications 
Carnation is not a weed in Europe, and in spite of cultivation for several centuries, there are 
no reports of establishment of escaped populations of cultivated carnation in Europe. The 
transformed lines have modified flower colour. Genes responsible for those colours are taken 
from higher plants and they are common in many plant species. There are no reasons to 
expect, that changed flower colour has any effect on the fitness characters (seed production, 
growth potential, winter survival, etc.) under natural conditions, compared to non-
transformed cultivars. 
The transgenic line also contains the als gene, a mutated acetolactate synthase (als) gene 
from tobacco. Due to ALS protein, the transgenic carnations have enhanced resistance to 
herbicides with sulfonylurea as an active component. This enzyme is important for 
production of amino acids leucine, isoleucine and valine. Resistance to sulfonylurea is used 
during in vitro cultivation to select the transformed cells from the untransformed ones. 
Herbicides with sulfonylurea are used in Norway to control annual dicotyledonous weeds in 
cereal fields (http://www.plantevernguiden.no). Resistance to this type of herbicides is 
rather common, mainly due to mutations in the als gene (Tranel and Wright, 2002). 
Sulfonylurea resistance in populations of common chickweed (Stellaria media) has been 
found in Norway (Fykse, 2004). Establishment of carnation populations in nature from cut 
flowers is highly unlikely, and presence of the als gene will not increase the probability of 
such establishment.  
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 5.3  Potential for gene transfer 
 Plant to micro-organisms gene transfer 5.3.1
Experimental studies have shown that gene transfer from transgenic plants to bacteria rarely 
occurs under natural conditions and that such transfer depends on the presence of DNA 
sequence similarity between the DNA of the transgenic plant and the DNA of the bacterial 
recipient (Bensasson et al., 2004; de Vries and Wackernagel, 2002; EFSA, 2004; EFSA, 
2009b; Nielsen et al., 2000; VKM, 2005). 
In the case of carnation, possibility for horizontal gene transfer may occur when the 
transgenic plants are spilled or discarded. Unintended spill of the imported plants is 
negligible, and the used carnations are discarded as domestic and public waste. Based on 
established scientific knowledge of the barriers for gene transfer between unrelated species, 
likelihood of random transfer of the transgenes present in these carnation lines to 
microorganisms is highly unlikely. All of the genes used are already found in natural plant 
populations, and none of the used genes (F3’5’H, Cytb5, als) are expected to give any 
competition advantage to microorganisms. Thus, environmentally harmful horizontal gene 
transfer from the GM carnation lines to microorganisms is highly unlikely.  
 Plant to plant gene flow 5.3.2
Hybrids D. caryophyllus x D. deltoids and D. caryophyllus x D. barbatus have been made by 
hand pollination (Umiel et al., 1987), but no spontaneous hybrids between carnation and 
other Dianthus-species have been reported (OGTR, 2006).  Due to the marginal pollen 
production and low vitality of pollen in cultivated carnation cultivars, gene transfer by 
pollination to other cultivars of carnation or to other species of Dianthus is highly unlikely. 
Even in the case of successful pollination, vase life of cut flowers (one to two weeks) is not 
long enough to for production of viable seeds, which normally takes five to eight weeks 
(OGTR, 2006).  
5.4 Interaction between the GM plant and target organisms  
With the intended use as cut flowers, interaction between carnation Moonvelvet IFD-26407-2 
and any target organisms is not an issue.  
5.5 Interaction between the GM plant and non-target 
organisms  
There are several herbivorous pests of the carnation and they could be affected by a change 
in delphinidin/cyanidin ratio. However, imported flowers will be used for decoration, mainly 
indoors, the local quantities are low, and the longevity of the flowers is short. Therefore, the 
exposure of herbivores to the transgenic carnations is very low. It is highly unlikely that non-
target organisms will be affected as a result of import of transgenic carnations in question.  
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 5.6 Potential interactions with the abiotic environment and 
biochemical cycles 
The transgenic carnation lines are used as cut flowers and discarded in domestic or public 
waste. Dispersed quantities of organic mass are low, and all the genes used are already 
present in nature. It is highly unlikely that the intended use of carnation Moonvelvet IFD-
26407-2 will have any adverse effect on abiotic environment or biochemical cycles.  
5.7 Conclusion 
Considering the intended use of Moonvelvet IFD-26407-2, which excludes cultivation and use 
as food or feed, the environmental risk assessment is concerned with accidental release into 
the environment of viable seeds/pollen, and rooted plants during transportation and 
distribution. 
With the exception of herbicide-tolerance, Moonvelvet IFD-26407-2 has no altered survival, 
multiplication or dissemination characteristics compared to conventional carnation cultivars, 
and there are no indications of an increased likelihood of spread and establishment of feral 
carnation plants in the case of accidental release into the environment. Carnations are 
cultivated in Norway but plant to plant gene flow is not considered to be an issue due to low 
pollen spread and viability and low likelihood of seed development from cut flowers. 
Based on current knowledge and considering its import, distribution and intended use as cut 
ornamental flowers, the VKM GMO Panel concludes that carnation Moonvelvet IFD-26407-2 
does not represent an environmental risk in Norway. 
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 6 Post-market environmental 
monitoring 
Directive 2001/18/EC introduces an obligation for applicants to implement monitoring plans, 
in order to trace and identify any direct or indirect, immediate, delayed or unanticipated 
effects on human health or the environment of GMOs as or in products after they have been 
placed on the market. Monitoring plans should be designed according to Annex VII of the 
Directive. According to Annex VII, the objectives of an environmental monitoring plan are 1) 
to confirm that any assumption regarding the occurrence and impact of potential adverse 
effects of the GMO or its use in the environmental risk assessment (ERA) are correct, and (2) 
to identify the occurrence of adverse effects of the GMO or its use on human health or the 
environment which were not anticipated in the environmental risk assessment. 
Post-market environmental monitoring is composed of case-specific monitoring and general 
surveillance (EFSA 2011c). Case-specific monitoring is not obligatory, but may be required to 
verify assumptions and conclusions of the ERA, whereas general surveillance is mandatory, 
in order to take account for general or unspecific scientific uncertainty and any unanticipated 
adverse effects associated with the release and management of a GM plant. Due to different 
objectives between case-specific monitoring and general surveillance, their underlying 
concepts differ. Case-specific monitoring should enable the determination of whether and to 
what extent adverse effects anticipated in the environmental risk assessment occur during 
the commercial use of a GM plant, and thus to relate observed changes to specific risks. It is 
triggered by scientific uncertainty that was identified in the ERA. 
The objective of general surveillance is to identify unanticipated adverse effects of the GM 
plant or its use on human health and the environment that were not predicted or specifically 
identified during the ERA. In contrast to case-specific monitoring, the general status of the 
environment that is associated with the use of the GM plant is monitored without any 
preconceived hypothesis, in order to detect any possible effects that were not anticipated in 
the ERA, or that are long-term or cumulative.  
The potential exposure to the environment of carnation Moonvelvet IFD-26407-2 would be 
mainly through (1) unintended release into the environment of GM carnations obtained by 
vegetative multiplication, (2) pollen dispersal from GM cut flowers to other carnations and 
wild relatives, (3) dispersal of seeds produced by GM cut flowers and possible progeny and 
(4) discarded GM carnation cut flowers resulting in possible exposure of environmental 
bacteria to recombinant DNA. 
The PMEM plan proposed by the applicant includes (1) a questionnaire for the European 
importers and operators, including questions on unexpected adverse effects; (2) the 
consultation of a network of taxonomists and botanists to report on any wild populations or 
unusual Dianthus hybrids that might originate from the GM carnation; (3) European 
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consumers are invited to comment on Florigene products with all Florigene contact details. 
The names and locations of our importer customers will be listed on the website. The 
applicant proposes to submit a PMEM report on an annual basis. 
The VKM GMO Panel is of the opinion that the scope of the monitoring plan provided by the 
applicant is in line with the restricted intended uses of carnation Moonvelvet IFD-26407-2. 
No specific environmental impact of genetically modified carnation Moonvelvet IFD-26407-2 
was indicated by the environmental risk assessment and thus no case specific monitoring is 
required. 
6.1 Conclusion 
The objectives of a monitoring plan according to Annex VII of Directive 2001/18/EC are to 
confirm that any assumption regarding the occurrence and impact of potential adverse 
effects of the GMO, or its use, in the environmental risk assessment are correct and to 
identify the occurrence of adverse effects of the GMO, or its use, on human health or the 
environment which were not anticipated in the environmental risk assessment. 
Based on current knowledge and considering its import, distribution and intended use as cut 
ornamental flowers, the VKM GMO Panel concludes that the environmental risk assessment 
did not identify any potential adverse environmental effects of the transgenic line of 
carnation Moonvelvet IFD-26407-2. Thus, the general post-market surveillance plan is 
sufficient and there is no need for a specific post-market surveillance plan.  
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 7 Conclusions 
Molecular characterisation  
The molecular characterisation provided by the applicant shows that Carnation Moonvelvet 
IFD-26407-2 contains one transgenic locus with the full length transfer-DNA-sequence (T-
DNA) from the transformation vector pCGP2355. The transferred T-DNA includes functional 
single copies of each of the three genes f3′5′h, cytb5 and als. Southern blot and PCR 
analyses indicate that no plasmid backbone sequences were integrated. Sequence analyses 
show no disruption of known endogenous genes. Bioinformatic analyses of putative 
translation products from new open reading frames (ORFs) within the insert and junction 
sites returned no relevant similarities to known toxins. Partial identities were indicated for 
the ALS protein and two ORFs with known allergens, however these similarities are 
considered negligible. Presence of transcripts corresponding to the f3′5′h, cytb5 and als 
genes in petals was shown by Northern blot analysis. Expression levels were not quantified. 
Activity of F3’5’H and Cytb5 enzymes and production of delphinidin was further indicated by 
the altered flower colour and metabolite analysis with both thin layer chromatography (TLC) 
and high-pressure liquid chromatography (HPLC). The level of delphinidin in flowers of 
Moonvelvet IFD-26407-2 was approximately 2.87 mg/g fresh weight. Tolerance to 
sulfonylurea herbicides indicated the activity of the ALS protein. No relevant changes in the 
introduced trait, i.e. the particular flower colour, have been reported during cultivation of 
carnation of Moonvelvet IFD-26407-2, indicating genetic stability. 
Based on current knowledge and the information provided by the applicant, the VKM GMO 
panel concludes that the molecular characterisation of carnation Moonvelvet IFD-26407-2 
does not indicate a safety concern  
Comparative assessment 
Considering the intended use of Moonvelvet IFD-26407-2, which excludes cultivation and use 
in food and feed, compositional studies were limited to the content of the three anthocyanin 
pigments delphinidin, cyanidin and pelargonidin. Compared to its non-GM parental cultivar 
Cerise Westpearl (CW), carnation Moonvelvet IFD-26407-2 petals contained higher levels of 
delphinidin and cyanidin and lower levels of pelargonidin, confirming the intended effects of 
the genetic modification. Other morphological traits were assessed and revealed that along 
with differing petal colour, carnation Moonvelvet IFD-26407-2 differed significantly in 10 
traits compared to carnation CW. None of the reported differences in compositional or 
morphological traits were expected to influence the risk scenario upon accidental release to 
the environment or intake of the GM carnation. 
Based on current knowledge and information provided by the applicant, and considering the 
intended use of carnation Moonvelvet IFD-26407-2, which excludes cultivation and use as 
food or feed, the VKM GMO Panel concludes that the comparative analysis of the newly 
synthesised anthocyanin pigments delphinidin, cyanidin and pelargonidin in its petals is 
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sufficient for the risk assessment. The reported morphological differences between 
Moonvelvet IFD-26407-2 and its conventional carnation counterpart CW do not raise safety 
concerns. 
Food and feed risk assessment 
An in vitro mutagenicity test (Ames test) with Salmonella typhimurium has been performed 
by the applicant on aqueous extracts from leaves and petals from carnation Moonvelvet IFD-
26407-2. The test did not reveal adverse effects of the extracts. The CYTB5, F3’5’H and ALS 
proteins do not show sequence resemblance to known toxins or IgE-dependent allergens, 
nor have they been reported to cause IgE-mediated allergic reactions. The anthocyanins 
delphinidin and cyanidin expressed as a result of the genetic modification are normally 
present in numerous plant foods and are authorised as food additives.  
Based on current knowledge, information supplied by the applicant, and considering the 
intended use, which excludes cultivation and use as food and feed, the VKM GMO Panel 
concludes that carnation Moonvelvet IFD-26407-2 is as safe as its conventional counterpart, 
carnation CW. It is unlikely that the CYTB5, F3’5’H or ALS proteins, or the delphinidin or 
cyanidin pigments, will introduce a toxic or allergenic potential in carnation Moonvelvet IFD-
26407-2. 
Environmental assessment 
Considering the intended use of Moonvelvet IFD-26407-2, which excludes cultivation and use 
as food or feed, the environmental risk assessment is concerned with accidental release into 
the environment of viable seeds/pollen, and rooted plants during transportation and 
distribution. 
With the exception of herbicide-tolerance, Moonvelvet IFD-26407-2 has no altered survival, 
multiplication or dissemination characteristics compared to conventional carnation cultivars, 
and there are no indications of an increased likelihood of spread and establishment of feral 
carnation plants in the case of accidental release into the environment. Carnations are 
cultivated in Norway but plant to plant gene flow is not considered to be an issue due to low 
pollen spread and viability and low likelihood of seed development from cut flowers. 
Based on current knowledge and considering its import, distribution and intended use as cut 
ornamental flowers, the VKM GMO Panel concludes that carnation Moonvelvet IFD-26407-2 
does not represent an environmental risk in Norway. 
Post-market environmental monitoring 
The objectives of a monitoring plan according to Annex VII of Directive 2001/18/EC are to 
confirm that any assumption regarding the occurrence and impact of potential adverse 
effects of the GMO, or its use, in the environmental risk assessment are correct and to 
identify the occurrence of adverse effects of the GMO, or its use, on human health or the 
environment which were not anticipated in the environmental risk assessment. 
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Based on current knowledge and considering its import, distribution and intended use as cut 
ornamental flowers, the VKM GMO Panel concludes that the environmental risk assessment 
did not identify any potential adverse environmental effects of the transgenic line of 
carnation Moonvelvet IFD-26407-2. Thus, the general post-market surveillance plan is 
sufficient and there is no need for a specific post-market surveillance plan. 
Overall conclusion 
Considering that carnation Moonvelvet IFD-26407-2 is not intended for cultivation or use as 
food or feed, the VKM GMO Panel considers that the comparative analysis of the newly 
synthesised anthocyanin pigments delphinidin, cyanidin and pelargonidin in its petals is 
sufficient for the risk assessment. The reported morphological differences between 
Moonvelvet IFD-26407-2 and its conventional carnation counterpart Cerise Westpearl (CW) 
do not raise safety concerns.  
Based on current knowledge, information supplied by the applicant, and considering the 
intended use, which excludes cultivation and use as food and feed, the VKM GMO Panel 
concludes that Moonvelvet IFD-26407-2 is as safe as its conventional counterpart CW. It is 
unlikely that the CYTB5, F3’5’H or ALS proteins, or the delphinidin or cyanidin pigments, will 
introduce a toxic or allergenic potential in carnation Moonvelvet IFD-26407-2. 
Likewise, the VKM GMO Panel concludes that carnation Moonvelvet IFD-26407-2, based on 
current knowledge, and intended use as cut flowers, does not represent an environmental 
risk in Norway. 
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 8 Data gaps 
Generally, carnations have no or very limited history of use in food and feed, and their 
content of nutrients, antinutritional factors and other components with biological activity is 
largely unknown. The import of carnation Moonvelvet IFD-26407-2 into the EU or Norway is 
not intended for food or feed use, nor for cultivation, and therefore components other than 
the anthocyanins delphinidin, cyanidin, petunidin and pelargonidin have not been analysed in 
carnation Moonvelvet IFD-26407-2 (EFSA, 2006b) or other GM carnations (EFSA, 2008; 
EFSA, 2014a; EFSA, 2014b). The comparative compositional assessment as defined in EFSA 
guidance documents for GM plants and derived food and feed (EFSA, 2006a) was therefore 
only partially applied and possible unintended effects of the genetic modification in carnation 
Moonvelvet IFD-26407-2 cannot be assessed.  
Furthermore, ornamental plants may become popular as foodstuff species due to their 
intrinsic nutritional value, antioxidant capacity and attractive appearance (Mlcek and Rop, 
2011). Flower species of Dianthus, Chrysanthemum and Viola have been found to possess 
high levels of mineral elements, with potassium being the most abundant element observed 
(Rop et al., 2012) and as such may be considered to have health benefits (Chandler et al., 
2013). Thus, the possible use of carnation Moonvelvet IFD-26407-2 as food, dietary 
supplements or garnish (edible decoration) in food cannot be entirely ruled out. A need for a 
health risk assessment associated with such occasional consumption has therefore been 
suggested (Chandler et al., 2013). 
Thus, more comprehensive compositional analysis and food safety assessments of 
Moonvelvet IFD-26407-2 are merited. 
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Scientific Opinion on a notification (reference C/NL/09/02) for the placing 
on the market of the genetically modified carnation IFD-26407-2 with a 
modified colour, for import of cut flowers for ornamental use, under Part C 
of Directive 2001/18/EC from Florigene
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ABSTRACT 
Genetically modified (GM) carnation IFD-26407-2 was developed to express anthocyanins in the petals 
conferring a mauve colour to the flowers. The GM carnation is intended to be imported in the European Union as 
cut flower for ornamental use only. Based on the molecular characterisation data, the Scientific Panel on 
Genetically Modified Organisms of the European Food Safety Authority (EFSA GMO Panel) confirms the 
stability of the newly introduced trait and the absence of disruption of known endogenous genes. Since 
anthocyanins are common pigments in many food plants, it is not expected that accidental intake of petals of 
carnation IFD-26407-2 would contribute substantially to the overall intake of anthocyanins from foods. 
Considering the ornamental use of cut flowers, and the limited exposure scenarios expected, the EFSA GMO 
Panel identified no reasons for any food safety concerns relating to carnation IFD-26407-2. The EFSA GMO 
Panel is also of the opinion that accidental release of GM carnations into the environment would not give rise to 
environmental safety concerns. The EFSA GMO Panel agrees with the methodology, including reporting 
intervals, proposed for post-market environmental monitoring. In response to the European Commission, the 
EFSA GMO Panel concludes that, in the light of the ornamental use of carnation IFD-26407-2 cut flowers, there 
is no scientific reason to consider that the placing on the market of the GM carnation will cause any adverse 
effects on human health or the environment. 
© European Food Safety Authority, 2014 
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carnation, cut flower, delphinidin, Dianthus caryophyllus, Directive 2001/18/EC, import, petal colour 
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SUMMARY 
Following a request from the European Commission, the Scientific Panel on Genetically Modified 
Organisms of the European Food Safety Authority (EFSA GMO Panel) was asked to deliver a 
scientific opinion on notification C/NL/09/02 from Florigene submitted under Part C of Directive 
2001/18/EC
4
. The scope of notification C/NL/09/02 covers the import, distribution and retailing in the 
European Union (EU) of genetically modified (GM) carnation IFD-26407-2 cut flowers for 
ornamental use only. 
In accordance with Directive 2001/18/EC, an assessment of the GM carnation was requested by the 
European Commission in order to address the outstanding objections raised by some Member States 
following the evaluation at the national level and to assess the overall safety of the GM carnation. The 
EFSA GMO Panel was, therefore, asked to consider if there is any scientific reason to believe that the 
placing on the market of the GM carnation IFD-26407-2 for import is likely to cause any adverse 
effects on human health or the environment. 
In delivering the present scientific opinion, the EFSA GMO Panel considered the full notification 
C/NL/09/02, including additional information provided by the notifier, the assessment report of the 
Dutch competent authority, the concerns raised by Member States, relevant scientific publications and 
the experience gained in assessing GM carnations with similar traits (EFSA, 2006a, 2008; EFSA 
GMO Panel, 2014). The EFSA GMO Panel performed its risk assessment in accordance with the 
principles of its guidance documents on the risk assessment of GM plants for non-food or non-feed 
purposes (EFSA, 2009a) and on the environmental risk assessment of GM plants (EFSA GMO Panel, 
2010). It should be noted that the comparative compositional assessment as defined in the EFSA 
guidance documents (EFSA, 2006b; EFSA GMO Panel, 2011a) could not be applied to identify 
possible unintended effects of carnation IFD-26407-2. 
The scientific evaluation by the EFSA GMO Panel included molecular characterisation of the inserted 
DNA and expression of the new proteins. A comparative evaluation of the morphological 
characteristics was undertaken, and the safety of the newly expressed proteins and of the whole GM 
plant was evaluated with respect to potential toxicity and allergenicity. The potential environmental 
impacts of accidental release of GM carnations into the environment and the post-market 
environmental monitoring (PMEM) plan proposed by the notifier were evaluated in the context of the 
scope of notification C/NL/09/02. 
Carnation IFD-26407-2 has a modified flower colour, a shade of mauve, whereas the parental line has 
a cerise flower colour. The colour has been achieved by introducing into the parental carnation two 
expression cassettes which, together with other genes of the anthocyanin biosynthesis pathway already 
present in the non-GM carnation, give rise to the anthocyanins delphinidin and cyanidin, the same 
compounds that give colour to blueberry, blackcurrant and red grape. Carnation IFD-26407-2 is also 
tolerant to sulfonylurea herbicides, but this newly introduced trait was used only for the selection of 
transformed plants and not for plant protection purposes. 
Carnation IFD-26407-2 was developed by Agrobacterium tumefaciens-mediated transformation of 
conventional carnation Cerise Westpearl. The desired colour was obtained by introducing the 
cytochrome b5 (cytb5) and flavonoid 3′,5′-hydroxylase (f3′5′h) coding sequences from Petunia sp. 
Tolerance to sulfonylurea herbicides was conferred by the expression of a mutated als gene. The 
molecular characterisation data establish that carnation IFD-26407-2 contains a single insert consisting 
of the three expression cassettes. The stability of the newly introduced trait (mauve flower colour) was 
observed over multiple generations. Bioinformatic analyses of the 5′ and 3′ flanking regions of the 
insert did not reveal disruption of known endogenous genes. Identities with allergens were found in 
putative translation products of open reading frames (ORFs) newly created by the genetic 
                                                     
4 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, 17.4.2001, p. 1–
39.  
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modification, but the likelihood that they are both transcribed and translated in carnation IFD-26407-2 
was considered negligible. 
Considering the scope of the notification and focusing on the limited information provided by the 
notifier, the EFSA GMO Panel is of the opinion that the altered flower colour and the differences 
observed for some morphological characteristics are not expected to influence the risk scenario of 
accidental intake of the GM carnation. 
It is not expected that accidental intake of petals of carnation IFD-26407-2 would contribute 
substantially to the overall intake of anthocyanins from foods. Considering the scope of notification 
C/NL/09/02 and given that case reports of occupational allergies to carnations are rare, there are no 
indications that the genetic modification will increase the risk of allergy among those coming into 
contact with carnations. Considering the scope of notification C/NL/09/02 and the limited exposure 
scenarios expected, the EFSA GMO Panel identified no reasons for any safety concerns of carnation 
IFD-26407-2. 
Carnation IFD-26407-2 cut flowers have marginal viability, negligible pollen production and few or 
no viable seeds. However, in the very unlikely event of escape into the environment via pollen/seeds 
or rooted plants, the EFSA GMO Panel considers that carnation IFD-26407-2 would not show 
enhanced fitness characteristics, except when exposed to sulfonylurea herbicides. Considering the 
scope of notification C/NL/09/02 and the low level of exposure to the environment, interactions with 
the biotic and abiotic environment are not considered to be relevant issues by the EFSA GMO Panel. 
The EFSA GMO Panel also concludes that the unlikely, but theoretically possible, horizontal gene 
transfer of recombinant genes from carnation IFD-26407-2 to environmental bacteria does not give 
rise to environmental safety concerns. The scope of the PMEM plan provided by the notifier is in line 
with the intended use of carnation IFD-26407-2. The EFSA GMO Panel agrees with the general 
methods and approaches, including reporting intervals, proposed by the notifier in its PMEM plan. 
In the light of the scope of notification C/NL/09/02 (import, distribution and retailing in the EU of 
carnation IFD-26407-2 cut flowers for ornamental use only), the EFSA GMO Panel concludes that 
there is no scientific reason to consider that the placing on the market of the GM carnation IFD-26407-
2 will cause any adverse effects on human health or the environment. 
Scientific Opinion on GM carnation IFD-26407-2 for import of cut flowers in EU 
 
EFSA Journal 2014;12(12):3935 4 
TABLE OF CONTENTS 
Abstract .................................................................................................................................................... 1 
Summary .................................................................................................................................................. 2 
Table of contents ...................................................................................................................................... 4 
1. Introduction ..................................................................................................................................... 5 
1.1. Background and Terms of Reference as provided by requestor ............................................. 5 
2. Data and methodologies .................................................................................................................. 6 
2.1. Data ......................................................................................................................................... 6 
2.2. Methodologies......................................................................................................................... 6 
3. Assessment ...................................................................................................................................... 6 
3.1. Molecular characterisation ...................................................................................................... 6 
3.1.1. Concerns raised by Member States..................................................................................... 6 
3.1.2. Evaluation of relevant scientific data ................................................................................. 6 
3.1.3. Conclusion .......................................................................................................................... 7 
3.2. Comparative analysis .............................................................................................................. 8 
3.2.1. Concerns raised by Member States..................................................................................... 8 
3.2.2. Evaluation of relevant scientific data ................................................................................. 8 
3.2.3. Conclusion .......................................................................................................................... 8 
3.3. Food/feed safety assessment ................................................................................................... 9 
3.3.1. Concerns raised by Member States..................................................................................... 9 
3.3.2. Evaluation of relevant scientific data ................................................................................. 9 
3.3.3. Conclusion ........................................................................................................................ 10 
3.4. Environmental risk assessment and post-market environmental monitoring plan ................ 11 
3.4.1. Concerns raised by Member States................................................................................... 11 
3.4.2. Evaluation of relevant scientific data ............................................................................... 11 
3.4.3. Environmental risk assessment ......................................................................................... 11 
3.4.4. Post-market environmental monitoring ............................................................................ 15 
3.4.5. Conclusion ........................................................................................................................ 16 
4. Conclusions ................................................................................................................................... 16 
Documentation provided to EFSA ......................................................................................................... 16 
References .............................................................................................................................................. 17 
  
Scientific Opinion on GM carnation IFD-26407-2 for import of cut flowers in EU 
 
EFSA Journal 2014;12(12):3935 5 
1. Introduction 
Carnation IFD-26407-2 is a genetically modified (GM) variety of Dianthus caryophyllus L. used as a 
decorative plant species. The dark mauve colour of the flowers results from the expression of two 
newly introduced genes encoding cytochrome b5 (cytb5) and flavonoid 3′,5′-hydroxylase (f3′5′h) 
which, together with endogenous genes in the anthocyanin biosynthesis pathway, enable the 
biosynthesis of delphinidin in the petals. Carnation IFD-26407-2 also contains a mutated herbicide 
tolerance als gene coding for an acetolactate synthase (ALS) variant protein, used to facilitate the 
selection of GM shoots during the genetic transformation process. 
In the present scientific opinion, the GM carnation IFD-26407-2 is evaluated by the Scientific Panel 
on Genetically Modified Organisms of the European Food Safety Authority (EFSA GMO Panel) in the 
light of the scope of notification C/NL/09/02 (import, distribution and retailing in the European Union 
(EU) of GM carnation cut flowers for ornamental use only). 
Therefore, the EFSA GMO Panel evaluated the safety of carnation IFD-26407-2 for humans 
considering three possible routes of exposure through (1) dermal contact, (2) inhalation and (3) 
accidental oral intake
5
. Owing to the scope of this notification, the EFSA GMO Panel did not assess 
the possible consequences of the intentional consumption of GM carnations by humans
6
. In relation to 
animals, both intentional and accidental oral intake were excluded from this opinion, as carnation IFD-
26407-2 is not expected to enter the feed chain or to be accidentally consumed in the field (cultivation 
being excluded from the scope) (EFSA, 2009a). 
Moreover, considering the scope of this notification, a very limited environmental exposure with 
respect to viable plant parts of the GM carnation is expected. Hence, the environmental risk 
assessment (ERA) is mainly concerned with the consequences of exposure through: (1) unintended 
release into the environment of GM carnations obtained by vegetative multiplication, (2) pollen 
dispersal from GM cut flowers to other carnations and wild relatives, (3) dispersal of seeds produced 
by GM cut flowers and possible progeny, and (4) discarded GM carnation cut flowers resulting in 
possible exposure of environmental bacteria to recombinant DNA. 
1.1. Background and Terms of Reference as provided by requestor 
In July 2009, the European Commission received the full notification (reference C/NL/09/02), together 
with the positive assessment report from the competent authority of the lead Member State, The 
Netherlands. 
In accordance with Directive 2001/18/EC
7
, the notification was then transmitted to the competent 
authorities of other Member States. Some of them raised comments and objections during the statutory 
60-day consultation period. The notifier, Florigene, provided the Member States with additional 
information in response to those comments and objections. However, some Member States maintained 
their reservations at the end of the additional 45-day consultation period, in which case, the European 
Commission is required to follow the procedure of Article 18(1) of Directive 2001/18/EC. In 
accordance with Article 18(1), the European Commission therefore consulted the EFSA GMO Panel 
for a scientific opinion. 
Against this background, the EFSA GMO Panel identified mainly general comments rather than 
reasoned objections as in the sense of Directive 2001/18/EC. Moreover, concerns raised by Member 
States that relate to, for example, traceability, labelling, socio-economics, molecular detection 
methodologies and their validation fall outside the remit of EFSA or its GMO Panel. 
                                                     
5 Accidental oral intake should be considered as unintentional, infrequent and/or of relatively short duration. 
6 The EFSA GMO Panel is aware of a food habit in certain populations to intentionally consume carnation petals as garnish; 
however, this intentional use is outside the scope of this notification. 
7 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, 17.4.2001, p. 1–
39.  
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EFSA is requested, in accordance with Article 28 of Directive 2001/18/EC, to provide a scientific 
opinion as to whether there is any scientific reason to believe that the placing on the market of the GM 
carnation line IFD-26407-2 for import is likely to cause any adverse effects on human health and the 
environment within the scope of Directive 2001/18/EC. 
2. Data and methodologies 
2.1. Data 
The present evaluation of the safety of the GM carnation IFD-26407-2 by the EFSA GMO Panel is 
based on the information provided in notification C/NL/09/02, including additional information
8
 
provided by the notifier, the assessment report of the Dutch competent authority, the concerns raised 
by Member States, relevant scientific publications and the experience gained in assessing GM 
carnations with similar traits (EFSA, 2006a, 2008; EFSA GMO Panel, 2014). 
2.2. Methodologies 
The EFSA GMO Panel performed its risk assessment in accordance with the principles of its guidance 
documents on the risk assessment of GM plants for non-food or non-feed purposes (EFSA, 2009a) and 
on the environmental risk assessment (ERA) of GM plants (EFSA GMO Panel, 2010). 
3. Assessment 
3.1. Molecular characterisation 
3.1.1. Concerns raised by Member States 
No objection raised by any Member State remained at the end of the 45-day Member States’ 
consultation period. Therefore, notwithstanding its own risk analysis, the EFSA GMO Panel had no 
specific concerns to address from the Member States on the molecular characterisation of GM 
carnation IFD-26407-2. 
3.1.2. Evaluation of relevant scientific data 
3.1.2.1. Transformation process and vector constructs 
To develop line IFD-26407-2, carnation variety Cerise Westpearl (CW) was transformed using 
disarmed Agrobacterium tumefaciens (also known as Rhizobium radiobacter) strain AGL0, which 
carried the transformation vector pCGP2355. 
The transformation vector pCGP2355 contained the following expression cassettes, needed to obtain 
the desired flower colour: 
1. the cytochrome b5 (cytb5) cassette, consisting of the promoter fragment from Antirrhinum 
majus chalcone synthase (CHS) gene, the cytb5 (difF) complementary DNA (cDNA) from 
Petunia × hybrida and the terminator sequence of a gene encoding a Petunia × hybrida 
putative phospholipid transfer protein homologue; 
2. the flavonoid 3′,5′-hydroxylase (f3′5′h) cassette, consisting of a chimeric f3′5′h gene 
constructed from the Petunia × hybrida f3′5′h cDNA, and the promoter and terminator 
fragments of a Dianthus caryophyllus anthocyanidin synthase (ans) gene. 
These two cassettes were inserted into the plant genome to obtain the desired flower colour. In 
addition, the vector pCGP2355 contained the acetolactate synthase cassette (als), consisting of the 
Cauliflower mosaic virus (CaMV) 35S promoter, and the coding region and the terminator sequence 
                                                     
8 See section ‘Documentation provided to EFSA’ below. 
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from als from the SuRB locus of Nicotiana tabacum. Acetolactate synthase provided tolerance to 
sulfonylurea herbicides, which was used as a marker trait in the selection of transformants. 
3.1.2.2. Transgene constructs in the genetically modified plants 
Carnation IFD-26407-2 contains one insert consisting of the transfer DNA (T-DNA) region of the 
transformation vector pCGP2355. Southern blot and polymerase chain reaction (PCR) analyses 
indicated that no plasmid backbone sequences had been integrated into carnation IFD-26407-2. The 
sequences of the insert and the flanking regions were provided. 
Bioinformatic analysis of the 5′ and 3′ flanking regions did not reveal disruption of known endogenous 
genes. 
In order to assess if the open reading frames (ORFs) present within the insert and spanning the 
junction sites give rise to any safety issues, their putative translation products were compared to 
appropriate databases for similarities to known allergens and toxins by using suitable algorithms. 
There were no significant hits with known toxins. By using an 80-amino-acid sliding window 
approach, a 35 % sequence identity was found within the newly expressed protein ALS with a 
Davidiella tassiana protein (see section 3.3.2.2). By using the same approach, identity of over 35 % 
was found with allergen ‘Amb a 4’ from common ragweed Ambrosia artemisiifolia for ORF 5.211 
within the insert. The putative translation product of ORF 5.211 is a 110-amino-acid sequence, 
generated from the reverse strand. The sequence corresponds to a section of the als gene encoded by 
the forward strand of the als gene cassette. Considering that ORF 5.211 is not in the codon frame 
intended to be expressed and does not include an ATG start codon, the likelihood that it is both 
transcribed and translated in carnation IFD-26407-2 is negligible. Furthermore, northern blot analysis 
did not reveal any other bands than the one expected for als. Searches of eight contiguous amino acids 
showed identity to a subtilisin protease allergen in Bacillus licheniformis for ORF 6.114 within the 
insert, putatively encoding a 25-amino-acid peptide. Considering that ORF 6.114 is not on the DNA 
strand of the insert intended to be transcribed and does not include an ATG, the likelihood that it is 
both transcribed and translated in carnation IFD-26407-2 is negligible. 
3.1.2.3. Information on the expression of the insert 
The presence of transcripts corresponding to f3′5′h, cytb5 and als genes in the petals was demonstrated 
using northern blot analysis. Confirmation of the functionality of the f3′5′h and cytb5 genes and of the 
production of delphinidin in petals was obtained visually from the flower colour, as well as from 
metabolite analysis using high-performance liquid chromatography (HPLC). Tolerance to sulfonylurea 
herbicides indicates the activity of the ALS protein. 
3.1.2.4. Inheritance and stability of the inserted DNA 
Carnation IFD-26407-2 was propagated vegetatively from January 2005 to September 2008, which 
represents multiple cycles of propagation. Furthermore, during 2007–2013, plants were cultivated in a 
field trial in Colombia and there were no reported incidents of flower colour change that would 
indicate genetic instability. 
3.1.3. Conclusion 
The molecular characterisation data establish that the carnation line IFD-26407-2 contains one insert, 
consisting of three expression cassettes responsible for the intended traits, i.e. dark mauve flower 
colour from the cytb5 and f3′5′h cassettes and herbicide tolerance by the mutated als gene. 
The results of bioinformatic analyses of the insert and flanking regions in carnation IFD-26407-2 did 
not indicate relevant similarities with known toxins. Identities with allergens were found in putative 
translation products of ORFs newly created by the genetic modification, but the likelihood that they 
are both transcribed and translated in carnation IFD-26407-2 is negligible. Sequence identity was 
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found between the newly expressed protein ALS and an allergen from Davidiella tassiana. The safety 
relevance of this sequence identity is assessed in section 3.3.2.2. 
3.2. Comparative analysis 
3.2.1. Concerns raised by Member States 
No objection remained among Member States concerning the comparative analysis of GM carnation 
IFD-26407-2 at the end of the 45-day Member States’ consultation period. 
3.2.2. Evaluation of relevant scientific data 
Considering that there is no history of the use of carnations as food or feed to a significant degree, that 
the safety of carnations per se has never been assessed for food/feed uses and that the compositional 
profile of carnations is not known, the comparative compositional assessment as defined in the EFSA 
guidance documents (EFSA, 2006b; EFSA GMO Panel, 2011a) could not be applied to identify 
possible unintended effects in carnation IFD-26407-2 (see section 1 for further details). 
3.2.2.1. Choice of comparator 
Carnation IFD-26407-2 was compared with the non-GM carnation variety Cerise Westpearl (CW) 
which was the variety of carnation that was transformed to establish carnation IFD-26407-2. Carnation 
CW is characterised by cerise petals. 
3.2.2.2. Compositional analysis 
The contents of the anthocyanin colour pigments delphinidin, cyanidin and pelargonidin were 
determined in acetonitrile extracts of freeze-dried petals using HPLC in accordance with the method of 
Fukui et al. (2003). As these anthocyanins occur as glycosylated and/or acylated compounds in the 
plant, the analytical method used a hydrolysis step converting the pigments into their aglycones, 
allowing the determination of total delphinidin, total cyanidin and total pelargonidin and not the 
specific compounds in the plant. 
The cerise flower petals of the comparator CW contained only cyanidin pigments (0.01 mg/g fresh 
weight (fw)) and pelargonidin pigments (1.06 mg/g fw), whereas those of the GM mauve-coloured 
carnation IFD-26407-2 contained delphinidin (2.87 mg/g fw), cyanidin (0.37 mg/g fw) and 
pelargonidin (0.01 mg/g fw). Delphinidin-based pigments were not observed in other plant tissues of 
the transgenic plants (stem, nodes, leaves and roots). This has been confirmed by HPLC studies of leaf 
and root material. 
The altered levels and types of anthocyanins in carnation IFD-26407-2 account for the intended 
phenotypic changes in the flower colour. The altered flower colour is not expected to influence the 
risk scenario of accidental intake of the GM carnation. 
3.2.2.3. Morphological traits and genetically modified phenotype 
In total, 18 morphological characteristics were analysed in carnation IFD-26407-2 and its comparator 
(carnation CW) grown in a field trial in Australia, during the 2007–2008 season. An analysis of 
variance (ANOVA) identified eight significant differences between the GM carnation and its 
comparator. Thus, carnation IFD-26407-2 had a lower number of internodes per stem, a thinner stem 
at the fifth node, shorter leaves at the third node, an increased calyx diameter, longer styles, less viable 
anthers, more filaments and a reduced filament length. In addition, the average number of days to 
flowering was shorter in carnation IFD-26407-2 than in carnation CW: 131 and 146 days, respectively. 
3.2.3. Conclusion 
Considering the scope of the notification and focusing on the limited information provided by the 
notifier, the EFSA GMO Panel is of the opinion that the altered flower colour and the differences 
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observed for some morphological characteristics are not expected to influence the risk scenario of 
accidental intake of the GM carnation. The relevance of the observed morphological differences for 
their potential environmental impacts is further assessed in section 3.4.3.1. 
3.3. Food/feed safety assessment 
3.3.1. Concerns raised by Member States 
No objection remained among Member States concerning the safety assessment of GM carnation IFD-
26407-2 for humans at the end of the 45-day Member States’ consultation period. 
The possible need for an acute toxicity study with whole plant extracts to support the assessment of 
this GM carnation in relation to accidental intake by humans was suggested by a Member State and 
was also discussed by the EFSA GMO Panel. Such a study was not considered necessary, as the safety 
assessment is sufficiently supported by the available data (see sections 3.3.2.1(a) and (b)). 
3.3.2. Evaluation of relevant scientific data 
3.3.2.1. Toxicology 
(a) Toxicological assessment of newly expressed proteins 
Bioinformatic analyses of the amino acid sequences of the newly expressed proteins in carnation IFD-
26407-2 reveal no significant similarities to known toxins to humans. 
The EFSA GMO Panel has previously assessed the safety of the ALS and F3′5′H proteins and no 
reasons for concern were identified (EFSA, 2006a, 2008). 
(b) Toxicological assessment of new constituents other than proteins 
The anthocyanins delphinidin and cyanidin are present in carnation IFD-26407-2 at higher levels than 
in the non-GM carnation. These anthocyanins can also be found in many foods and in some of them at 
much higher concentrations than in the petals of carnation IFD-26407-2. Particularly high 
concentrations can be found, for example, in blackcurrants, aubergines, blueberries and red grapes 
(Cacho et al., 1992). According to Regulation 1333/2008
9
 on food additives, anthocyanins (E 163) are 
authorised food additives in the EU. Anthocyanins have been evaluated by the Scientific Committee 
on Foods (SCF), which concluded that anthocyanins prepared by physical processes from natural 
foods are acceptable for use in food without further investigations. The SCF indicated that 
anthocyanins derived from natural sources are only acceptable as food additives if the quantities 
ingested do not differ substantially from the amounts that are likely to be ingested as a result of the 
normal consumption of the foods in which they occur naturally (SCF, 1975). In the re-evaluation of 
anthocyanins, the Scientific Panel on Food Additives and Nutrient Sources Added to Food of the 
EFSA (EFSA ANS Panel, 2013) concluded that, provided that exposure from the use of food colours 
is comparable to that from the diet, the conclusion on safety in the 1975 opinion would still apply to 
anthocyanins extracted by aqueous processes from edible fruits and vegetables. 
It is not expected that the accidental intake of petals of carnation IFD-26407-2 would contribute 
substantially to the overall intake of anthocyanins from foods. Therefore, the EFSA GMO Panel sees 
no reason for concern regarding the presence of delphinidin and cyanidin in petals of carnation IFD-
26407-2. 
In addition, the notifier also performed a study on gene mutations in bacteria using Salmonella 
enterica Typhimurium (Ames test) with water extracts of leaves or petals of carnation IFD-26407-2 
                                                     
9 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ 
L 354, 31.12.2008, p. 16–33. 
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and the control carnation CW. The water extracts did not show mutagenic activity under the conditions 
of the assay. 
(c) Toxicological assessment of the whole genetically modified plant 
Given that carnation IFD-26407-2 is not intended for human consumption as food but is intended for 
ornamental use only, the EFSA GMO Panel considered the possible effects of the genetic modification 
on human health in the case of accidental intake (EFSA, 2009a). Considering the assessment of the 
newly expressed proteins (section 3.3.2.1(a)) and of the new constituents other than proteins (section 
3.3.2.1(b)), the EFSA GMO Panel identified no reasons for concern. 
3.3.2.2. Allergenicity 
(a) Allergenicity assessment of newly expressed proteins 
Bioinformatic analyses of the amino acid sequence of the newly expressed proteins in carnation IFD-
26407-2 using the criterion of more than 35 % identity in a segment of 80 or more amino acids (Codex 
Alimentarius, 2003) revealed no significant similarities to known allergens. In addition, the notifier 
performed analyses searching for matches of eight contiguous identical amino acid sequences between 
these newly expressed proteins and known allergens, which confirmed the outcome of the above-
mentioned bioinformatic analyses showing no similarities to known allergens. 
The EFSA GMO Panel has previously assessed the safety of the ALS and F3′5′H proteins and no 
reasons for concern were identified (EFSA, 2006a, 2008). 
The EFSA GMO Panel noted that 35 % sequence identity over a window of 80 amino acids between 
the ALS protein and an allergen from Davidiella tassiana was reported. However, this hit was not 
considered relevant because the percentage of identity was not greater than 35 % and, in addition, a 
high E-value
10
 was seen. 
(b) Allergenicity assessment of the whole genetically modified plant 
Occupational allergy (dermal and respiratory allergy) to carnations in workers handling cut 
flowers/carnations over a long time has been described (Sanchez-Guerrero et al., 1999; Cistero-
Bahima et al., 2000; Sanchez-Fernandez et al., 2004; Stefanaki and Pitsios, 2008)
11
. This allergy could 
be caused by the flower, by mites such as Tetranychus urticae infesting carnations or by both 
simultaneously. Nevertheless, case reports of occupational allergies to carnations are rare. 
More recently, a case report of an individual with a respiratory allergy to carnations with no 
occupational exposure was published (Brinia et al., 2013)
11
. 
According to the notifier, no adverse reactions (including allergenicity or contact dermatitis) to GM 
carnation IFD-26407-2 cut flowers used for ornamental purposes have been reported in the 
populations handling the flowers (growers, distributors and purchasers) where it is produced and/or 
marketed
11
. 
Considering the scope of notification C/NL/09/02 and given that case reports of occupational allergies 
to carnations are rare, there are no indications that the genetic modification will increase the risk of 
allergy among those coming into contact with carnations. 
3.3.3. Conclusion 
Carnation flowers have a long history of use as ornamentals. Carnation IFD-26407-2 differs from the 
non-GM carnation in that it synthesises anthocyanins, mainly delphinidin and cyanidin, in the petals, 
                                                     
10 An alignment derived from a FASTA search of a database is accompanied with an E-value, which represents the number of 
times the corresponding alignment score is expected at chance. 
11 Additional information 28 August 2014. 
Scientific Opinion on GM carnation IFD-26407-2 for import of cut flowers in EU 
 
EFSA Journal 2014;12(12):3935 11 
which confer a mauve colour to the flowers. Delphinidin and cyanidin are common pigments in many 
ornamental flowers and food plants such as red grapes, blackcurrants, aubergines and blueberries. It is 
not expected that accidental intake of petals of carnation IFD-26407-2 would contribute substantially 
to the overall intake of anthocyanins from foods. 
Considering the scope of notification C/NL/09/02 and given that case reports of occupational allergies 
to carnations are rare, there are no indications that the genetic modification will increase the risk of 
allergy among those coming into contact with carnations. 
Considering the scope of notification C/NL/09/02 and the limited exposure scenarios expected, the 
EFSA GMO Panel identified no reasons for any safety concerns of carnation IFD-26407-2. 
3.4. Environmental risk assessment and post-market environmental monitoring plan 
3.4.1. Concerns raised by Member States 
Some Member States expressed concerns related to the possible illegal propagation of carnation IFD-
26407-2 through vegetative multiplication by individuals. More details on the methods and 
implementation of the post-market environmental monitoring (PMEM) plan were requested by some 
Member States. 
3.4.2. Evaluation of relevant scientific data 
Considering the scope of notification C/NL/09/02, there will be very limited environmental exposure 
with respect to viable plant parts of the GM carnation. The ERA is mainly concerned with the 
consequences of exposure through: (1) unintended release into the environment of GM carnations 
obtained by vegetative multiplication, (2) pollen dispersal from GM cut flowers to other carnations 
and wild relatives, (3) dispersal of seeds produced by GM cut flowers and possible progeny and (4) 
discarded GM carnation cut flowers resulting in possible exposure of environmental bacteria to 
recombinant DNA. 
3.4.3. Environmental risk assessment12 
3.4.3.1. Potential unintended effects on plant fitness due to the genetic modification 
Carnation is the common name of Dianthus caryophyllus (i.e. cultivated carnation). Members of the 
genus Dianthus, including wild and domesticated species, are fairly diverse, as their origins range 
from southern Russia to the Alpine region of Greece and the Auvergne mountains of France. Dianthus 
spp. are adapted to the cooler Alpine regions of Europe and Asia, and are also found in Mediterranean 
coastal regions. D. caryophyllus is a widely cultivated ornamental plant in Europe both in glasshouses 
and outdoors (i.e. in Italy and Spain) and is occasionally naturalised in some Mediterranean countries 
but appears to be restricted to the coastal Mediterranean regions of Greece, Italy, Sicily, Corsica and 
Sardinia (Tutin et al., 1993). 
Although Dianthus spp. do not spread vegetatively through organs such as bulbs, stolons or rhizomes, 
the cultivated carnation can be vegetatively propagated to produce plants for cut flower production. 
Cuttings are taken from ‘mother plants/stems’ which are continually pruned to produce a large number 
of vegetative cuttings from axillary buds. These cuttings are rooted in conditions of high humidity 
after treatment to encourage root growth. Rooted plants may be planted in soil or grown 
hydroponically, and are kept for one to two years. Flowers are produced in flushes, beginning three to 
five months after rooted cuttings are planted. 
The majority of Dianthus spp. is self-sterile because the stigma is not receptive to pollen until one 
week or more after anthers have shed pollen. Cultivated carnations require pollination by hand to set 
seed (Bird, 1994). As a result of the long history of use of vegetative propagation and selection for 
                                                     
12 Notification C/NL/09/02, Section B. 
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flower characteristics, the carnation produces only a negligible amount of pollen, and consequently 
seed set is low or absent (Galbally and Galbally, 1997). The quantity and quality of pollen varies with 
the cultivar (Kho and Baer, 1973; Galbally and Galbally, 1997). Carnation pollen is heavy and sticky 
and has low viability. Wind plays little role in pollen dispersal (OGTR, 2006). In the wild, cross-
pollination of Dianthus spp. is by insect pollinators, in particular by Lepidoptera, which have 
probosces of sufficient length to reach the nectaries at the base of the flowers. 
Carnation IFD-26407-2 has a modified flower colour resulting from the expression of two newly 
introduced genes encoding cytb5 and f3′5′h, which, together with endogenous genes in the 
anthocyanin biosynthesis pathway, enable the biosynthesis of delphinidin in the petals. These 
anthocyanins are also widely found, for example, in flowers of the genus Petunia (Ando et al., 1999), 
Rosa (Biolley and Jay, 1993) or Chrysanthemum (Schwinn et al., 1993; Andersen et al., 2000). There 
is no evidence that the presence of delphinidin and cyanidin would lead to effects on plant fitness. 
Carnation IFD-26407-2 contains a mutated als gene conferring tolerance to sulfonylurea herbicides. 
Given that the ALS enzyme is needed for the biosynthesis of some branched-chain amino acids such 
as isoleucine, ALS-inhibiting herbicides cause the death of the plant by interfering with this 
biosynthesis pathway. In relation to this, Tranel and Wright (2002) reported that tolerance to ALS-
inhibiting herbicides was widespread among weeds and was mostly due to a mutated als gene. In 
addition, the ALS-tolerant biotype was shown to be less sensitive to feedback inhibition by branched-
chain amino acids. This results in greater accumulation of branched-chain amino acids in tolerant 
biotypes, which may allow seeds from tolerant biotypes to germinate more rapidly, especially in cool 
temperatures. This may indicate a possible change in behaviour of the tolerant plants in the absence of 
herbicide selection in the very unlikely event of escape into the environment. Wild Dianthus 
populations exhibit a diversity of phenotypes exploiting niches in a wide geographical range in Europe 
(Tutin et al., 1993). The EFSA GMO Panel considered that a small change in seed germination 
characteristics induced by ALS tolerance is unlikely to be outside the current range of seed 
germination characteristics currently expressed by non-GM carnations and thus is unlikely to have an 
ecological impact. 
In the very unlikely event of gene transfer to cultivated carnations, they may express the mutated als 
gene conferring tolerance to sulfonylurea herbicides. This could result in a possible fitness advantage 
and higher weediness of the tolerant plants in the presence of these herbicides and those with a similar 
mode of action. However, these herbicides are not known to be used
13
 on cultivated carnations. Such 
herbicide-tolerant plants can be managed by a range of measures (Tranel and Wright, 2002). There is 
no evidence that the traits introduced by the genetic modification result in increased persistence and 
invasiveness of a plant species. 
In general, carnation varieties compete poorly outside their cultivated environment. In addition, 
carnation varieties do not show weedy characteristics. In notification C/NL/09/02, the notifier 
presented morphological or phenotypic data gathered from a field trial conducted in Australia during 
the 2007–2008 season (see section 3.2.2.3)14. A total15 of 18 morphological characteristics were 
evaluated for the GM carnation, in comparison with the parental line CW. Statistically significant 
differences were observed between the GM carnation and its parental line for 8 out of the 18 
characteristics studied. Carnation IFD-26407-2 had a lower number of internodes per stem, a thinner 
stem at the fifth node, shorter leaves at the third node, an increased calyx diameter, longer styles, less 
viable anthers, more filaments and a reduced filament length. The notifier attributed these variations in 
morphological characters to environmental factors. The notifier also reported from the 2007–2008 
Australian field trial a lower average number of days to flowering for the GM carnation than its 
                                                     
13 See additional information provided by the notifier to Member States after the 60-day consultation period. 
14 Notification C/NL/09/02, Attachment A12. 
15 Plant height (mm), number of internodes per stem, length of fifth node (mm), thickness of fifth node (mm), leaf length of 
third node from the top (mm), height of corolla (mm), flower diameter (mm), calyx diameter (mm), calyx length (mm), 
number of lobes per calyx, number of petals per flower, petal length (mm), petal width (mm), number of styles, style 
length (mm), number of viable anthers, filament length (mm), number of filaments. 
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parental line. A reduction in the number of days to flowering would not bring any selective advantage 
to the GM carnation or its progeny and therefore could not be associated with a different or increased 
fitness potential. The EFSA GMO Panel is of the opinion that, owing to their morphological nature, 
these characteristics for which differences were observed are unlikely to affect the survival, 
establishment and fitness of the GM carnation. 
Moreover, the EFSA GMO Panel is not aware of any scientific reports of increased spread and 
establishment of (GM) carnations or of any change in survival capacity, including overwintering 
(COGEM report
16
; EFSA, 2006a, 2008). In addition, D. caryophyllus has been imported into all EU 
countries as a garden ornamental plant and cut flower for many decades and EFSA is not aware of any 
reports of feral populations that have established outside of cultivation. 
In order to assess the likelihood of unintended effects on the environment, the EFSA GMO Panel 
followed a weight-of-evidence approach in collating and assessing appropriate information from 
various data sources (e.g. molecular data, available phenotypic data from a field trial performed by the 
notifier, literature and previous evaluations of similar transformation events (EFSA, 2006a, 2008; 
EFSA GMO Panel, 2014)). Therefore, considering the scope of notification C/NL/09/02 and the data 
available, the EFSA GMO Panel considered that there would be very little exposure of other Dianthus 
populations and no changes in plant characteristics of any ecological significance. Carnation IFD-
26407-2 plants would show changed fitness characteristics only when exposed to sulfonylurea 
herbicides, but these herbicides are not used in carnation cultivation or in habitats where wild 
Dianthus spp. might occur. The EFSA GMO Panel also concludes that the propagation of the GM 
carnation (e.g. rooting) by individuals cannot be excluded. However, should this occur, carnation IFD-
26407-2 would not show any potential for increased survival, fitness or weediness compared with its 
parental line. 
3.4.3.2. Potential for gene transfer 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
through either horizontal gene transfer of DNA or vertical gene flow via seed dispersal and cross-
pollination. 
(a) Plant-to-bacteria gene transfer 
Considering the scope of notification C/NL/09/02, the ERA is concerned with exposure through 
discarded GM carnation cut flowers resulting in possible exposure of environmental bacteria to 
recombinant DNA. If accidental intake of these GM carnations by humans occurs
17
 (see section 3.3), it 
is likely to be at very low levels so that exposure of gastro-intestinal tract bacteria and microfloral 
decomposers of faecal material will be very low. 
Current scientific knowledge of recombination processes in bacteria indicates that horizontal transfer 
of non-mobile, chromosomally located DNA fragments between unrelated organisms (such as plants 
to microorganisms) is not likely to occur at detectable frequencies under natural conditions (see EFSA, 
2009b, for further details). 
Successful horizontal gene transfer would require the stable insertion of the transgene sequences into a 
bacterial genome and a selective advantage conferred to the transformed host. The only known 
mechanism that facilitates horizontal transfer of non-mobile, chromosomal DNA fragments to 
bacterial genomes is homologous recombination. This requires the presence of stretches of DNA 
sequences that are similar in the recombining DNA molecules and, in addition to substitutive gene 
replacement, facilitates the insertion of non-homologous DNA sequences if their flanking regions have 
sequence similarity with bacterial sequences in the recipient. 
                                                     
16 Available online: http://www.cogem.net/index.cfm/en/publications/publicatie/advisory-report-import-distribution-and-
retail-of-cut-flowers-with-modified-flower-colour-gm-carnation-shd-27531-4 
17 Accidental oral intake should be considered as unintentional, infrequent and/or of relatively short duration. 
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Carnation IFD-26407-2 does not contain genetic elements with identity or high similarity to those of 
bacteria. The recombinant genetic elements used for the construction of carnation IFD-26407-2 
originate from plants, i.e. Petunia, Antirrhinum, Dianthus and Nicotiana tabacum (tobacco) (for more 
details, see section 3.1.2.1). Owing to the absence of DNA with high similarity to bacteria, there is no 
indication of facilitated transfer of recombinant genes to bacteria when it is compared with the transfer 
of genes from non-GM carnations. Thus, based on the data provided by the notifier, no increased 
likelihood for horizontal gene transfer from carnation IFD-26407-2 to environmental bacteria is 
expected. The EFSA GMO Panel could not identify any selective advantage which would be provided 
to environmental bacteria when receiving the recombinant DNA of carnation IFD-26407-2. 
Therefore, considering the scope of notification C/NL/09/02, the EFSA GMO Panel concluded that the 
unlikely, but theoretically possible, horizontal gene transfer of recombinant genes from carnation IFD-
26407-2 to environmental bacteria does not give rise to environmental safety concerns. 
(b) Plant-to-plant gene transfer 
Considering the scope of notification C/NL/09/02, the ERA is mainly concerned with indirect 
exposure through (1) unintended release into the environment of GM carnations obtained by 
vegetative multiplication, (2) pollen dispersal from GM cut flowers to other carnations and wild 
relatives and (3) dispersal of seeds produced by GM cut flowers and possible progeny. 
Carnation IFD-26407-2 plants are imported as cut flowers and thus have no roots and only occasional 
vegetative buds. The cut stems with vegetative shoots could be propagated by rooting or by micro-
propagation. The latter is a multiplication technique applied in the laboratory which requires particular 
expertise and adequate material for successful tissue culture. The EFSA GMO Panel is of the opinion 
that this technique is unlikely to be used by individuals (e.g. amateur gardeners) to propagate GM 
carnations. However, the GM carnation could be propagated by rooting and then released into the 
environment (e.g. gardens). The EFSA GMO Panel therefore considered the consequences of such 
potential releases (see section 3.4.3.1) and concluded that, should this occur, carnation IFD-26407-2 
would not show any potential for increased survival, fitness or weediness compared with its parental 
line. 
Wind plays little role in pollen dispersal of Dianthus spp. (OGTR, 2006). In the wild, cross-pollination 
of Dianthus spp. is by insect pollinators, in particular by Lepidoptera, which have probosces of 
sufficient length to reach the nectaries at the base of the flowers. However, the GM carnation has 
double flowers with a high density of petals. These obstruct insect pollinators from probing the 
flowers to reach the nectaries and therefore discourage insect pollinator activity and limit the amount 
of pollen they collect and transfer to other flowers. The EFSA GMO Panel is of the opinion that the 
potential spread of pollen of the GM carnation by Lepidoptera to wild Dianthus spp. cannot be 
eliminated but is highly unlikely to occur and, if it did occur, it is very unlikely that viable hybrids 
would be produced, survive and cause adverse environmental effects (see section 3.4.3.1). 
Moreover, the reproductive biology of Dianthus (OGTR, 2006) and the information provided by the 
notifier suggest that pollen production by flowers and pollen viability are low. Moreover, in 
notification C/NL/09/01, the notifier pointed out that ‘flowers must be harvested in tight bud (or 
closed bud for spray types) for distribution and marketing’, which rules out pollination during 
production, but suggests it could occur post-marketing. However, the data indicate that pollen transfer 
to other carnations is very unlikely to occur owing to very low fertility levels in most carnations. In 
addition, viable seed production of cut flowers is very unlikely and has not been observed so far with 
carnation IFD-26407-2, most probably because of its limited life time (i.e. three weeks) in comparison 
with the time needed for complete seed development (i.e. five weeks). 
The EFSA GMO Panel also considered the possibility of natural exchange of genetic material with 
other carnation varieties, Dianthus caryophyllus L., and wild Dianthus species. Although hybridisation 
is mentioned in some floristic surveys, the EFSA GMO Panel is not aware of reports of gene flow 
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between cultivated carnations and wild Dianthus spp. in the literature. The probability of spontaneous 
hybridisation between GM carnations and other cultivated carnations or wild relatives, and then the 
establishment of viable hybrids, is considered to be very low. 
Therefore, taking account of the very low potentials for hybridisation and/or seed production of (GM) 
carnations, the EFSA GMO Panel concludes that plant-to-plant gene transfer of the introduced genes 
is very unlikely and, if it did occur, it is unlikely to result in viable seed production leading to adverse 
environmental effects. 
3.4.3.3. Potential interactions of the genetically modified plant with target organisms 
Considering the scope of notification C/NL/09/02 and the absence of target organisms, potential 
interactions of the GM plant with target organisms were not considered a relevant issue by the EFSA 
GMO Panel. 
3.4.3.4. Potential interactions of the genetically modified plant with non-target organisms 
Considering the scope of notification C/NL/09/02 and the low level of exposure to the environment, 
potential interactions of the GM plant with non-target organisms were not considered a relevant issue 
by the EFSA GMO Panel. 
3.4.3.5. Potential interactions with the abiotic environment and biogeochemical cycles 
Considering the scope of notification C/NL/09/02 and the low level of exposure to the environment, 
potential interactions with the abiotic environment and biogeochemical cycles were not considered a 
relevant issue by the EFSA GMO Panel. 
3.4.4. Post-market environmental monitoring18 
According to Annex VII of Directive 2001/18/EC, the objectives of a post-market environmental 
monitoring (PMEM) plan are: (1) to confirm that any assumption regarding the occurrence and impact 
of potential adverse effects of the GMO or its use in the ERA are correct; and (2) to identify the 
occurrence of adverse effects of the GMO or its use on human health or the environment that were not 
anticipated in the ERA. 
Monitoring is related to risk management, and thus a final adoption of the PMEM plan falls outside 
the mandate of EFSA. However, the EFSA GMO Panel gives its opinion on the scientific content of 
the PMEM plan provided by the notifier (EFSA GMO Panel, 2011b). The potential exposure to the 
environment of carnation IFD-26407-2 would be mainly through (1) unintended release into the 
environment of GM carnations obtained by vegetative multiplication, (2) pollen dispersal from GM 
cut flowers to other carnations and wild relatives, (3) dispersal of seeds produced by GM cut flowers 
and possible progeny and (4) discarded GM carnation cut flowers resulting in possible exposure of 
environmental bacteria to recombinant DNA. The scope of the PMEM plan provided by the notifier is 
in line with the restricted intended use of GM carnation cut flowers. 
The PMEM plan proposed by the notifier includes (1) a questionnaire for the European importers and 
operators, including questions on unexpected adverse effects and ‘illegal growing’; (2) the 
involvement of existing networks (i.e. national plant protection services); and (3) the consultation of a 
network of European taxonomists, botanists and breeders to report on any wild populations or unusual 
Dianthus hybrids that might originate from the GM carnation. In addition, the notifier plans to survey 
the production sites in Colombia and Ecuador to report diverse observations, including adverse effects 
and the incidence of genetic off-types. The notifier proposes to submit a PMEM report on an annual 
basis. The report will include, for example, the number of imported GM cut flowers and a report of the 
identified hybrids and of feral carnation populations, if any. 
                                                     
18 See notification C/NL/09/02, Section D. 
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The EFSA GMO Panel is of the opinion that the scope of the PMEM plan proposed by the notifier is 
in line with the restricted intended use of carnation IFD-26407-2, as the ERA did not cover cultivation 
and identified no potential adverse environmental effects. No case-specific monitoring is required. 
3.4.5. Conclusion 
Carnation IFD-26407-2 cut flowers have marginal viability, negligible pollen production and few or 
no viable seeds. However, in the very unlikely event of escape into the environment via pollen/seeds 
or rooted plants, the EFSA GMO Panel considers that carnation IFD-26407-2 would not show 
enhanced fitness characteristics, except when exposed to sulfonylurea herbicides. Considering the 
scope of notification C/NL/09/02 and the low level of exposure to the environment, interactions with 
the biotic and abiotic environment are not considered to be relevant issues by the EFSA GMO Panel. 
The EFSA GMO Panel also concluded that the unlikely, but theoretically possible, horizontal gene 
transfer of recombinant genes from carnation IFD-26407-2 to environmental bacteria does not give 
rise to environmental safety concerns. The scope of the PMEM plan provided by the notifier is in line 
with the intended use of carnation IFD-26407-2. The EFSA GMO Panel agreed with the general 
methods and approaches, including reporting intervals, proposed by the notifier in its PMEM plan. 
4. Conclusions 
In the light of the scope of notification C/NL/09/02 (import, distribution and retailing in the EU of 
carnation IFD-26407-2 cut flowers for ornamental use only), the EFSA GMO Panel concludes that 
there is no scientific reason to consider that the placing on the market of the GM carnation IFD-26407-
2 will cause any adverse effects on human health or the environment. 
DOCUMENTATION PROVIDED TO EFSA 
1. Notification C/NL/09/02 under Part C of Directive 2001/18/EC submitted by Florigene to the 
European Commission, and received from the European Commission on 4 April 2013. 
2. Letter from the European Commission, dated 4 April 2013, to the EFSA Executive Director 
concerning a request for the placing on the market of genetically modified carnation IFD-26407-2 
under Directive 2001/18/EC by Florigene. 
3. Acknowledgement letter, dated 7 June 2013, from EFSA to the European Commission. 
4. Letter from EFSA to the notifier, dated 24 July 2013, requesting additional information. 
5. Letter from the notifier to EFSA, received on 8 November 2013, providing additional information. 
6. Letter from EFSA to the notifier, dated 19 December 2013, requesting additional information. 
7. Letter from the notifier to EFSA, received on 23 December 2013, providing additional 
information. 
8. Letter from EFSA to the notifier, dated 3 April 2014, requesting additional information. 
9. Letter from the notifier to EFSA, received on 25 April 2014, providing additional information. 
10. Letter from EFSA to the notifier, dated 29 July 2014, requesting additional information. 
11. Letter from the notifier to EFSA, received on 26 August 2014, providing additional information. 
12. Letter from EFSA to the notifier, dated 2 October 2014, requesting additional information. 
13. Letter from the notifier to EFSA, received on 29 October 2014, providing additional information. 
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